Voice disturbances

R18_VOICE_DISTU

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R49 Hospital discharge: ICD-9 — 7844 Cause of death: ICD-10 — R49 Cause of death: ICD-9 — 7844 2 out of 7 registries used, show all original rules.	12515
4. Check minimum number of events None	12515
5. Include endpoints None	12515
6. Filter based on genotype QC (FinnGen only)	12117

Control definitions (FinnGen only)

Control exclude: R18_SYMPTOMS_SIGNS_INVOLVI_SPEECH_VOICE

Extra metadata

Level in the ICD hierarchy: 3
Special: VOICERESO
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R47-R49
Name in latin: Perturbationes vocis

NAME	R18_VOICE_DISTU
CONTROL_EXCLUDE	R18_SYMPTOMS_SIGNS_INVOLVI_SPEECH_VOICE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R49
HD_ICD_9	7844
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R49
COD_ICD_9	7844
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Voice disturbances based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12117	8335	3782
Unadjusted period prevalence (%)	2.57	2.96	1.73
Median age at first event (years)	57.03	53.44	64.93

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12515: Matched controls
125150

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R03BA02

ATC

budesonide; inhalant

2.4

319.3

2905

14230

R05

ICD-10 Finland

Cough

2.2

308.6

3376

17830

J37.0

ICD-10 Finland

Chronic laryngitis

12.0

307.7

1602

1514

R01AD09

ATC

mometasone; nasal

2.1

307.7

6554

43437

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

10.9

307.7

356

336

R23

ICPC

Voice symptom/complaint

11.2

307.7

1020

985

RL210, ,

NOMESCO Finland

43.8

307.7

316

R03DC03

ATC

montelukast; oral

3.1

307.7

3316

13115

R49

ICD-10 Finland

Voice disturbances

59.4

307.7

307

UDQ12

NOMESCO Finland

Flexible laryngoscopy

11.9

307.7

2777

2931

R49.0

ICD-10 Finland

Dysphonia

33.5

307.7

1732

598

R03BA08

ATC

ciclesonide; inhalant

4.0

307.7

2078

5964

J45.1

ICD-10 Finland

Nonallergic asthma

3.3

307.7

1404

4615

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

12.4

307.7

329

272

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

10.0

307.7

665

695

Z3226

NOMESCO Finland

Physiotherapist

2.4

307.7

2945

14100

R03AC02

ATC

salbutamol; inhalant

2.5

307.7

8176

54387

J04.0

ICD-10 Finland

Acute laryngitis

5.2

307.7

906

1843

R13

ICD-10 Finland

Dysphagia

3.5

307.7

1350

4200

A02BC05

ATC

esomeprazole; systemic

2.6

307.7

6625

38249

H02AB06

ATC

prednisolone; systemic

2.1

307.7

6812

45545

R49.08

ICD-10 Finland

Other specified dysphonia

521.2

307.7

3885

108

R4130

NOMESCO Finland

Speech therapy

12.8

307.7

1082

915

J45

ICD-10 Finland

Asthma

2.9

307.7

1919

7472

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

174.3

307.7

1651

109

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.6

307.7

3366

15443

Z50.5

ICD-10 Finland

Speech therapy

23.7

307.7

764

343

R49.01

ICD-10 Finland

Functional dysphonia

1221.6

307.7

5855

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.1

307.7

1642

5892

R49.1

ICD-10 Finland

Aphonia

85.2

307.7

348

J45.9

ICD-10 Finland

Asthma, unspecified

2.8

307.7

3441

15022

J38.2

ICD-10 Finland

Nodules of vocal cords

21.4

307.7

315

151

J38.3

ICD-10 Finland

Other diseases of vocal cords

14.3

307.7

501

363

R49.03

ICD-10 Finland

Atrophic dysphonia

990.2

307.7

1710

R49.09

ICD-10 Finland

Unspecified dysphonia

149.0

307.7

1462

111

A02BC02

ATC

pantoprazole; systemic

2.2

306.1

9259

70921

R49.02

ICD-10 Finland

Spasmodic dysphonia

+∞

305.4

292

R03AK08

ATC

formoterol and beclometasone; inhalant

3.9

304.2

964

2641

R06.0

ICD-10 Finland

Dyspnoea

2.1

303.6

3959

22377

R03BA05

ATC

fluticasone; inhalant

2.3

301.5

2894

14462

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.7

292.4

1783

7214

R03BB04

ATC

tiotropium bromide; inhalant

2.8

291.7

1670

6540

J38.4

ICD-10 Finland

Oedema of larynx

17.0

288.1

239

143

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

284.0

4228

24977

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.4

282.1

2255

10373

UDQ02

NOMESCO Finland

Direct laryngoscopy

11.2

279.5

297

272

A02BC03

ATC

lansoprazole; oral

2.0

269.5

4179

24954

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.1

267.8

1197

4079

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

7.8

260.9

367

485

R03AC13

ATC

formoterol; inhalant

3.4

254.5

972

3007

R03BA01

ATC

beclometasone; inhalant

2.3

246.7

2245

10872

R03AK07

ATC

formoterol and budesonide; inhalant

2.1

243.3

3108

17195

A02BC01

ATC

omeprazole; systemic

1.9

234.4

3863

23330

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

234.2

3304

18910

R96

ICPC

Asthma

2.5

228.3

1599

6874

R01AD08

ATC

fluticasone; nasal

1.9

227.4

4052

25063

J31.0

ICD-10 Finland

Chronic rhinitis

2.6

224.1

1408

5741

J01FA10

ATC

azithromycin; systemic

1.8

223.5

7612

57389

R01AD58

ATC

fluticasone, combinations; nasal

1.9

208.6

3436

20601

R06AX27

ATC

desloratadine; oral

1.9

208.3

3969

24939

R01AD12

ATC

fluticasone furoate; nasal

1.8

207.5

4306

27779

J01AA02

ATC

doxycycline; systemic

2.0

203.3

10060

83953

RP210, ,

NOMESCO Finland

26.0

201.0

139

R21

ICPC

Throat symptom/complaint

2.0

200.5

2847

16202

R03AC03

ATC

terbutaline; inhalant

2.2

199.0

2101

10723

J02AC01

ATC

fluconazole; systemic

1.8

196.0

5617

39671

Z2221

NOMESCO Finland

Medical doctor

1.8

194.5

3769

23707

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

194.3

4922

33533

XQ800

NOMESCO Finland

Prick test

2.6

194.1

1217

4942

J01FA06

ATC

roxithromycin; oral

1.8

194.1

5319

37059

A02BC04

ATC

rabeprazole; oral

2.5

193.5

1407

6129

J38.7

ICD-10 Finland

Other diseases of larynx

10.5

192.2

213

207

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.9

192.0

995

3663

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

187.6

6205

45420

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

180.8

3721

23735

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

180.3

3607

22808

DQE10

NOMESCO Finland

Injection of foreign material into vocal cord

16.9

179.5

149

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

179.3

5809

42093

R06AE07

ATC

cetirizine; oral

1.7

175.4

5816

42325

UDQ22

NOMESCO Finland

Microlaryngoscopy

8.7

171.3

218

255

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

170.7

1499

7072

R03AK11

ATC

formoterol and fluticasone; inhalant

4.0

170.4

498

1280

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

169.7

4987

35037

R05

ICPC

Cough

1.8

169.4

3278

20452

M79.6

ICD-10 Finland

Pain in limb

1.7

168.9

5516

39844

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

168.6

3735

24248

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

168.5

5692

41473

R07.0

ICD-10 Finland

Pain in throat

2.6

166.4

1089

4503

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

163.6

2555

14884

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.0

161.4

761

2653

J46

ICD-10 Finland

Status asthmaticus

3.6

158.9

536

1522

R03AC12

ATC

salmeterol; inhalant

3.0

158.0

735

2543

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

6.1

155.4

271

450

M25.5

ICD-10 Finland

Pain in joint

1.7

155.2

4245

29074

R4110

NOMESCO Finland

Physiotherapy

1.7

154.3

3593

23543

N03AX16

ATC

[U] pregabalin

1.8

154.2

3146

19850

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

153.3

3278

20959

N02AX02

ATC

tramadol; systemic, rectal

1.6

147.5

5406

39771

R02

ICPC

Shortness of breath/dyspnoea

2.0

146.2

1797

9614

J01FA09

ATC

clarithromycin; systemic

1.7

145.2

4079

28022

H02AB04

ATC

methylprednisolone; systemic

1.9

141.7

2018

11348

M54.5

ICD-10 Finland

Low back pain

1.6

139.6

4581

32661

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

139.4

6496

50393

R51.80

ICD-10 Finland

Headache

1.9

138.6

2087

11944

ZXE00

NOMESCO Finland

One hour or less

1.6

138.0

4907

35654

H02AB07

ATC

prednisone; oral

1.9

137.7

1873

10362

M03BX02

ATC

tizanidine; oral

1.6

136.7

7808

63445

Z71.8

ICD-10 Finland

Other specified counselling

1.7

134.5

3916

27034

R03BC03

ATC

nedocromil; inhalant

2.4

133.4

1038

4629

G44.2

ICD-10 Finland

Tension-type headache

1.9

133.1

1910

10748

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

131.9

1128

5236

R42

ICD-10 Finland

Dizziness and giddiness

1.7

131.9

2949

18965

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.6

131.2

453

1305

R74

ICPC

Upper respiratory infection acute

1.6

126.8

3909

27285

N03AX12

ATC

[U] gabapentin; oral

1.8

126.5

2182

12997

Z3231

NOMESCO Finland

Registered nurse

1.7

126.2

3406

22987

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

125.5

2638

16643

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

124.2

2335

14263

N06AX11

ATC

mirtazapine; oral

1.6

124.0

4257

30459

L17

ICPC

Foot/toe symptom/complaint

1.6

123.8

3664

25286

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

121.9

3933

27701

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.1

121.5

1295

6549

A02BA02

ATC

ranitidine; systemic

1.8

121.4

2440

15181

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

120.1

2999

19793

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

19.5

119.9

DQD34

NOMESCO Finland

Treatment of spasmodic dysfonia

207.0

118.8

123

R53

ICD-10 Finland

Malaise and fatigue

1.7

117.8

3000

19885

R03DA04

ATC

theophylline; systemic, rectal

2.6

114.6

688

2716

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.0

114.5

1355

7113

BAA60

NOMESCO Finland

Total thyroidectomy

3.3

114.4

442

1367

R47.1

ICD-10 Finland

Dysarthria and anarthria

135.8

113.3

121

R01AD01

ATC

beclometasone; nasal

1.8

112.9

2010

12046

J01CA04

ATC

amoxicillin; systemic

1.7

112.4

10048

88514

G47.3

ICD-10 Finland

Sleep apnoea

1.7

112.1

2700

17603

J01DB01

ATC

cefalexin; oral

1.7

112.0

10230

90574

C01CA24

ATC

epinephrine; parenteral

2.3

111.7

886

3975

H03AA01

ATC

levothyroxine sodium; systemic

1.6

111.5

3118

21114

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

111.3

1581

8828

L03

ICPC

Low back symptom/complaint

1.6

110.9

3477

24205

L01

ICPC

Neck symptom/complaint

1.8

110.7

2053

12445

UJF32

NOMESCO Finland

Coloscopy

1.6

110.2

3265

22416

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.5

109.4

708

2897

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

109.4

5453

42088

DQA10

NOMESCO Finland

Biopsy of larynx

8.3

108.8

143

174

R06AE09

ATC

levocetirizine; oral

1.8

108.7

1878

11144

D14.1

ICD-10 Finland

Benign neoplasm: Larynx

6.9

107.9

166

242

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

2.7

107.9

613

2353

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

106.1

4378

32379

F45.8

ICD-10 Finland

Other somatoform disorders

2.2

105.8

948

4472

R1260

NOMESCO Finland

Evaluation of communicative skills

4.4

105.5

268

619

E0000UV, ,

ATC

1.5

104.4

5102

39086

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

103.2

4569

34255

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

102.5

4213

31073

N02BE01

ATC

paracetamol; systemic, rectal

1.8

102.4

11066

100776

R06AX22

ATC

ebastine; oral

1.7

102.2

2223

14063

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

101.6

5083

39065

J20

ICD-10 Finland

Acute bronchitis

1.9

99.7

1353

7425

N06AX21

ATC

duloxetine; oral

1.8

97.7

1551

8946

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

97.5

1659

9775

A07AA02

ATC

nystatin; oral

2.3

97.3

814

3730

R47.0

ICD-10 Finland

Dysphasia and aphasia

22.3

96.8

S18

ICPC

Laceration/cut

1.5

96.8

5448

42744

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

96.7

3102

21586

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

95.9

4824

36982

J45.8

ICD-10 Finland

Mixed asthma

2.9

95.2

475

1702

J01DA01

ATC

[U] cefalexin

1.5

94.7

7490

62735

R01AD05

ATC

budesonide; nasal

2.1

93.7

1024

5206

R83

ICPC

Respiratory infection other

1.6

92.9

2998

20859

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

92.2

3126

21988

K07.60

ICD-10 Finland

Snapping jaw

2.3

91.4

723

3234

K30

ICD-10 Finland

Functional dyspepsia

1.8

90.7

1462

8462

R49.2

ICD-10 Finland

Hypernasality and hyponasality

885.0

89.9

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

89.5

8615

74590

A11

ICPC

Chest pain NOS

2.0

89.4

1049

5469

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

89.0

1306

7338

M01AH05

ATC

etoricoxib; oral

1.5

88.4

7504

63295

R52.9

ICD-10 Finland

Pain, unspecified

1.9

88.3

1270

7088

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

88.1

1084

5745

UJC01

NOMESCO Finland

Scopy of lower throat

5.1

86.7

183

363

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

84.5

919

4658

D01

ICPC

Abdominal pain/cramps general

1.8

84.1

1439

8466

J01MA02

ATC

ciprofloxacin; systemic

1.5

84.0

4534

34981

AA1AD

NOMESCO Finland

CT of head and brain

1.5

83.7

3097

22128

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

83.4

918

4674

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

82.9

714

3306

N05CF01

ATC

zopiclone; oral

1.5

82.8

3805

28424

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

82.2

2741

19129

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

82.1

2198

14575

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

82.0

1313

7570

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.5

82.0

523

2122

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.7

80.9

463

1781

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

80.6

1775

11197

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

79.9

771

3734

R12

ICD-10 Finland

Heartburn

1.9

79.8

1034

5569

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

2.9

79.6

374

1296

S29

ICPC

Skin symptom/complaint other

1.6

79.4

2282

15379

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.8

79.3

1374

8107

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

78.6

5153

41075

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.6

78.5

479

1902

M01AE02

ATC

naproxen; oral, rectal

1.4

78.3

6716

56157

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

77.8

1605

9941

L08

ICPC

Shoulder symptom/complaint

1.5

77.8

2604

18157

R06AX13

ATC

loratadine; oral

1.7

77.7

1825

11696

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

77.7

2367

16159

M01AB05

ATC

diclofenac; systemic, rectal

1.4

77.5

7918

68253

Z01.7

ICD-10 Finland

Laboratory examination

1.7

77.5

1755

11144

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.4

77.2

566

2447

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

77.1

2688

18906

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

77.1

1463

8855

ZXA00

NOMESCO Finland

Right side

1.5

76.8

3087

22375

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.1

76.7

756

3690

R07.3

ICD-10 Finland

Other chest pain

1.8

76.7

1243

7186

ZXA10

NOMESCO Finland

Bilateral

1.6

76.6

2211

14898

J38.5

ICD-10 Finland

Laryngeal spasm

10.7

76.6

C07AA05

ATC

propranolol; systemic

1.6

76.1

2439

16833

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

75.4

901

4718

R03DC01

ATC

zafirlukast; oral

3.5

74.7

266

781

A01AB09

ATC

miconazole; local oral

1.9

74.4

1086

6075

P01AB01

ATC

metronidazole; oral, rectal

1.4

74.4

4868

38671

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

74.1

8450

73965

ZXD20

NOMESCO Finland

Day surgery

1.7

74.0

1560

9712

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

73.9

509

2139

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

73.8

2046

13643

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

73.6

4827

38337

ZXA05

NOMESCO Finland

Left side

1.5

73.3

2856

20535

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

73.2

7829

67665

D38.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Larynx

7.2

72.6

108

152

M02AA07

ATC

piroxicam; topical

1.4

72.5

4212

32704

WX002

NOMESCO Finland

Sedation and analgesia

1.6

71.7

2286

15732

J30.3

ICD-10 Finland

Other allergic rhinitis

2.5

71.4

472

1946

104

Kela drug reimbursment

Thyroid insufficiency

1.9

71.3

952

5173

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

71.0

3444

25838

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

70.6

872

4615

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

3.1

69.9

298

977

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.5

69.9

467

1935

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

69.9

6495

54590

R03BB01

ATC

ipratropium bromide; inhalant

2.5

69.6

459

1890

C07AB07

ATC

bisoprolol; oral

1.4

69.4

5469

44686

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

69.2

2423

17006

N03AE01

ATC

clonazepam; systemic

2.1

69.1

726

3627

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

69.1

4269

33440

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

69.1

1712

11094

L12

ICPC

Hand/finger symptom/complaint

1.6

69.0

1916

12761

M79.1

ICD-10 Finland

Myalgia

1.6

68.8

1731

11260

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.8

68.7

356

1301

R01AD11

ATC

triamcinolone; nasal

1.8

68.6

1079

6173

Z01.2

ICD-10 Finland

Dental examination

1.4

68.4

5294

43090

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

68.2

1160

6791

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

68.1

4466

35328

A04

ICPC

Weakness/tiredness general

1.6

68.0

1687

10932

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

67.7

1140

6653

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.4

67.4

471

1992

J01DA06

ATC

[U] cefuroxime

1.6

67.2

1701

11075

SFA10

NOMESCO Finland

One-surface restoration

1.4

67.1

6362

53492

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

67.1

5481

44967

M54.2

ICD-10 Finland

Cervicalgia

1.9

67.0

973

5428

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

66.4

1546

9858

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

66.3

666

3272

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

66.1

1145

6738

RL130, ,

NOMESCO Finland

11.8

66.0

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.1

65.9

669

3300

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

65.6

626

3015

XF402

NOMESCO Finland

ECG with work load test

1.7

65.4

1220

7329

R35

ICD-10 Finland

Polyuria

2.0

65.4

768

3992

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

65.4

1670

10893

N06AA09

ATC

amitriptyline; systemic

1.7

64.4

1179

7044

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

64.3

2105

14532

UDC00

NOMESCO Finland

Ear microscopy

1.9

64.1

890

4893

A03FA02

ATC

cisapride; oral, rectal

1.9

64.1

904

4995

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

63.9

1477

9392

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

63.8

3200

24065

XKD00

NOMESCO Finland

Uroflowmetry

1.6

63.5

1533

9856

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.3

63.4

492

2179

R4120

NOMESCO Finland

Occupational therapy

2.0

63.3

781

4128

N05CF02

ATC

zolpidem; oral

1.5

63.0

2068

14276

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

62.8

5761

47974

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

3.4

62.7

226

669

R29

ICPC

Respiratory symptom/complaint other

1.9

62.7

809

4342

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

62.6

2916

21615

RL230, ,

NOMESCO Finland

313.7

62.4

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

62.4

2122

14762

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

62.3

1219

7416

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

6.5

62.3

102

159

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

62.2

969

5521

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.9

62.2

783

4168

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

61.9

1348

8437

A98

ICPC

Health maint/preventive medicine

2.2

61.8

12057

115445

J01FF01

ATC

clindamycin; systemic

1.4

61.2

3092

23249

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.5

61.1

385

1552

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

60.9

1398

8869

M01AC06

ATC

meloxicam; systemic, rectal

1.4

60.9

4258

33878

UKC02

NOMESCO Finland

Cystoscopy

1.6

60.8

1688

11216

N01

ICPC

Headache

1.7

60.7

1217

7450

R06.5

ICD-10 Finland

Mouth breathing

1.8

60.6

996

5764

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

60.5

1578

10328

N05BA04

ATC

oxazepam; oral

1.4

60.5

3004

22508

G24.8

ICD-10 Finland

Other dystonia

7.4

60.4

118

G04BD12

ATC

mirabegron; oral

1.7

60.4

1372

8679

M48.0

ICD-10 Finland

Spinal stenosis

1.6

60.3

1398

8890

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

2.7

59.7

327

1230

J01FA15

ATC

telithromycin; oral

1.7

59.4

1186

7251

KMAK, ,

NOMESCO Finland

1.4

59.3

5899

49579

SPAT1058

SPAT

PEF monitoring instruction

1.8

59.3

981

5688

N17

ICPC

Vertigo/dizziness

1.6

59.2

1406

8992

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

59.0

1000

5838

1420

FHL

Laryngomicroscopy

5.1

58.9

123

242

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

58.9

1628

10800

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

58.5

2626

19288

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

3.0

58.2

265

903

M01AH01

ATC

celecoxib; oral

1.5

58.0

2086

14657

J05AB01

ATC

aciclovir; systemic

1.5

57.5

2546

18644

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

3.5

57.4

203

594

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

57.3

1002

5901

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

57.2

934

5392

M01AX17

ATC

nimesulide; oral

1.4

56.9

2730

20286

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

56.7

1796

12279

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

56.6

1093

6619

S21

ICPC

Skin texture symptom/complaint

1.6

56.3

1609

10749

J34.2

ICD-10 Finland

Deviated nasal septum

2.1

55.5

575

2855

J01MA14

ATC

moxifloxacin; systemic

1.7

55.2

1022

6115

L02

ICPC

Back symptom/complaint

1.7

54.7

1147

7097

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

54.2

1116

6872

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

54.2

2088

14857

L28

ICPC

Limited function/disability (L)

1.5

54.1

1947

13661

SFA20

NOMESCO Finland

Two-surface restoration

1.3

54.1

6705

57911

N06AX16

ATC

venlafaxine; oral

1.6

54.1

1629

11004

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

54.0

2046

14507

R04.2

ICD-10 Finland

Haemoptysis

2.4

53.7

396

1715

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.0

53.7

155

395

R06AX26

ATC

fexofenadine; oral

1.8

53.5

823

4665

DHB50

NOMESCO Finland

Turbinoplasty

2.6

53.1

314

1228

D07AC01

ATC

betamethasone; topical

1.4

52.8

4055

32560

P06

ICPC

Sleep disturbance

1.6

52.7

1313

8482

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

52.7

3301

25650

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

52.6

4104

33026

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

52.5

2280

16599

J01EA01

ATC

trimethoprim; systemic

1.4

52.4

3089

23752

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

52.4

5441

45708

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

52.0

2864

21761

K08.80

ICD-10 Finland

Toothache NOS

1.7

52.0

1003

6068

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

51.9

1046

6401

A01AB04

ATC

amphotericin B; local oral

2.0

51.9

560

2821

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

51.7

1171

7388

F29

ICPC

Eye symptom/complaint other

1.7

51.6

1092

6770

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

51.4

765

4291

R52.2

ICD-10 Finland

Other chronic pain

2.2

51.4

458

2146

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

51.4

1361

8919

U02

ICPC

Urinary frequency/urgency

1.5

51.3

1664

11413

M01AH02

ATC

rofecoxib; oral

1.6

51.2

1441

9576

J01MA06

ATC

norfloxacin; oral

1.6

51.2

1538

10374

M79.7

ICD-10 Finland

Fibromyalgia

2.1

50.9

476

2273

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

3.0

50.8

222

739

EB1AA, ,

SPAT

1.8

50.2

767

4338

L13

ICPC

Hip symptom/complaint

1.5

50.1

2103

15192

RL390, ,

NOMESCO Finland

256.5

50.1

A01

ICPC

Pain general/multiple sites

1.7

49.9

1042

6434

K59.0

ICD-10 Finland

Constipation

1.9

49.9

645

3458

R51

ICD-10 Finland

Headache

1.9

49.7

648

3484

GD1AA, ,

SPAT

1.6

49.6

1277

8311

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.3

49.2

382

1691

N04BC05

ATC

pramipexole; oral

1.7

49.0

879

5207

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

2.8

48.9

241

858

D11

ICPC

Diarrhoea

1.6

48.7

1287

8423

L15

ICPC

Knee symptom/complaint

1.4

48.1

2687

20424

J05AB11

ATC

valaciclovir; oral

1.5

48.1

1652

11458

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

47.9

1914

13683

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

47.8

780

4497

RL330, ,

NOMESCO Finland

128.0

47.8

J37

ICD-10 Finland

Chronic laryngitis and laryngotracheitis

15.8

47.7

Z2446

NOMESCO Finland

Social worker

1.8

47.7

688

3821

WX402

NOMESCO Finland

General anaesthesia

1.4

47.2

2337

17384

XF404

NOMESCO Finland

Ambulatory ECG

1.7

47.1

960

5887

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

46.9

2359

17594

X58

ICD-10 Finland

Exposure to other specified factors

1.5

46.9

1480

10078

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.4

46.8

335

1432

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

46.7

912

5529

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

46.6

1009

6288

N06AB04

ATC

citalopram; systemic

1.4

46.5

2354

17574

N02BF01

ATC

gabapentin; oral

1.7

46.5

936

5721

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

46.5

1721

12114

R06.2

ICD-10 Finland

Wheezing

2.0

46.4

509

2580

D06

ICPC

Abdominal pain localized other

1.7

46.1

996

6200

G04CA02

ATC

tamsulosin; oral

1.5

46.1

1997

14488

M01AX05

ATC

glucosamine; oral

1.4

46.0

2140

15732

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

45.9

903

5484

C09CA06

ATC

candesartan; oral

1.4

45.9

2635

20096

A97

ICPC

No disease

1.5

45.8

1928

13912

J02AC02

ATC

itraconazole; systemic

1.4

45.8

2045

14921

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

45.7

531

2745

N06AB10

ATC

escitalopram; oral

1.4

45.6

2224

16487

J01MA12

ATC

levofloxacin; systemic

1.4

45.5

1980

14374

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

45.4

547

2864

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

45.3

2523

19138

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

45.3

555

2923

K02.1

ICD-10 Finland

Caries of dentine

1.3

45.2

6583

57497

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

45.2

1925

13919

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

45.1

1800

12852

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.0

45.1

196

651

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.3

45.1

335

1456

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

44.9

831

4964

D19

ICPC

Teeth/gum symptom/complaint

1.4

44.8

3090

24263

TAC00

NOMESCO Finland

Peripheral nerve block

5.5

44.5

158

SDA03

NOMESCO Finland

Periodontal treatment

1.3

44.2

4456

36987

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

43.9

2410

18222

H92.0

ICD-10 Finland

Otalgia

1.8

43.8

682

3877

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

43.7

3437

27516

XJC10

NOMESCO Finland

Oesophageal pH monitoring

4.8

43.6

202

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

43.4

670

3798

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

43.3

632

3522

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

43.3

1011

6417

C05AA08

ATC

fluocortolone; rectal, topical

1.5

43.2

1517

10554

N05AH04

ATC

quetiapine; oral

1.5

43.0

1818

13113

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

42.8

2985

23454

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

42.7

979

6184

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

42.5

2515

19242

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

42.5

2687

20784

H01

ICPC

Ear pain/earache

1.6

42.4

1234

8243

XA402

NOMESCO Finland

ENMG

2.4

42.2

308

1328

D07AC13

ATC

mometasone; topical

1.3

42.2

3183

25297

J47

ICD-10 Finland

Bronchiectasis

2.7

42.2

227

847

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.9

42.1

575

3137

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

42.1

1131

7420

SPAT1325

SPAT

Vaccination

1.3

42.0

3638

29498

ZX114

NOMESCO Finland

Intramuscular

2.9

41.9

193

663

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

41.8

384

1821

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

41.6

637

3601

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

41.4

855

5257

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

41.0

1085

7092

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.1

41.0

403

1962

K80

ICPC

Cardiac arrhythmia NOS

1.6

40.8

911

5713

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

40.8

3040

24095

A03CA02

ATC

clidinium and psycholeptics; oral

1.8

40.4

633

3604

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

40.3

1766

12813

ZXC10

NOMESCO Finland

Use of laser

2.5

40.3

259

1055

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

40.1

507

2698

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

40.0

1470

10310

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

39.7

3871

31857

R49.04

ICD-10 Finland

Dysplastic dysphonia

+∞

39.6

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

39.4

3263

26237

R00.2

ICD-10 Finland

Palpitations

1.6

39.4

878

5505

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

39.3

812

4991

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.7

39.2

212

793

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

39.1

2192

16592

J01DC02

ATC

cefuroxime; systemic

1.8

39.1

611

3475

N05BA01

ATC

diazepam; systemic, rectal

1.5

39.1

1368

9497

R2110

NOMESCO Finland

Giving the first information

1.7

39.0

786

4800

R55

ICD-10 Finland

Syncope and collapse

1.6

38.9

1123

7482

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

38.9

666

3890

R60.0

ICD-10 Finland

Localized oedema

1.5

38.9

1320

9107

R50.9

ICD-10 Finland

Fever, unspecified

1.5

38.8

1536

10926

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

6.5

38.6

S80.0

ICD-10 Finland

Contusion of knee

1.7

38.5

806

4971

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

38.4

1546

11030

TAB00

NOMESCO Finland

Lumbar puncture

1.9

38.3

485

2582

D12

ICPC

Constipation

2.1

38.3

392

1938

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

38.2

429

2191

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

38.2

647

3766

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

38.2

524

2862

H02

ICPC

Hearing complaint

1.5

38.1

1448

10216

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

38.0

919

5878

S04

ICPC

Lump/swelling localized

1.5

37.8

1108

7406

U07

ICPC

Urine symptom/complaint other

1.6

37.4

819

5108

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.6

37.4

1044

6903

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.5

37.3

235

948

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.6

37.3

217

843

H93.1

ICD-10 Finland

Tinnitus

1.7

37.3

752

4594

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.9

37.2

507

2763

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

37.2

1717

12562

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

3.8

37.1

113

300

D07AA02

ATC

hydrocortisone; topical

1.5

37.0

1439

10194

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

37.0

381

1887

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.0

37.0

392

1962

UJD02

NOMESCO Finland

Gastroscopy

1.9

36.9

514

2821

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

3.0

36.9

163

547

R63.4

ICD-10 Finland

Abnormal weight loss

2.0

36.8

413

2110

A06AC51

ATC

ispaghula, combinations; oral

1.8

36.7

547

3067

N06AA10

ATC

nortriptyline; systemic

2.4

36.6

257

1090

L16

ICPC

Ankle symptom/complaint

1.5

36.6

1223

8405

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

36.4

1026

6796

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

36.4

3115

25115

C10AA07

ATC

rosuvastatin; oral

1.3

36.3

3403

27780

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

36.3

1143

7757

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

36.2

1148

7800

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

36.1

1293

9011

G24.3

ICD-10 Finland

Spasmodic torticollis

3.3

36.0

134

406

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

35.8

1738

12821

L14

ICPC

Leg/thigh symptom/complaint

1.6

35.7

849

5406

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

35.6

941

6143

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

35.4

1377

9750

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.7

35.4

653

3894

D02

ICPC

Abdominal pain epigastric

1.7

35.2

669

4020

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

35.2

348

1698

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

35.1

375

1883

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

35.0

1166

8005

L57.0

ICD-10 Finland

Actinic keratosis

1.5

34.9

1080

7300

S06.0

ICD-10 Finland

Concussion

1.5

34.8

1080

7305

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.9

34.7

425

2237

UJH02

NOMESCO Finland

Anoscopy

1.9

34.7

465

2521

DJD20

NOMESCO Finland

Plastic repair of septum of nose

2.1

34.6

353

1743

H57.1

ICD-10 Finland

Ocular pain

1.9

34.5

412

2150

A03

ICPC

Fever

1.4

34.5

1695

12524

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

5.8

34.5

110

G50.1

ICD-10 Finland

Atypical facial pain

2.5

34.4

226

930

D06BX01

ATC

metronidazole; topical

1.5

34.4

1207

8372

G04BD08

ATC

solifenacin; oral

1.7

34.3

700

4287

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

34.1

598

3514

M54

ICD-10 Finland

Dorsalgia

1.5

34.1

1293

9106

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.5

34.1

1163

8020

Z50.1

ICD-10 Finland

Other physical therapy

1.8

34.1

578

3365

N06AB03

ATC

fluoxetine; oral

1.5

34.1

1330

9419

S82

ICPC

Naevus/mole

1.4

34.1

1428

10251

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

34.0

1082

7356

XG405

NOMESCO Finland

Education on PEF monitoring

2.7

34.0

183

684

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

33.9

307

1448

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

33.8

3616

29976

RL430, ,

NOMESCO Finland

92.8

33.7

G04CA01

ATC

alfuzosin; oral

1.5

33.7

1000

6698

D03

ICPC

Heartburn

2.0

33.6

391

2022

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

3.5

33.6

113

321

J04.2

ICD-10 Finland

Acute laryngotracheitis

4.0

33.5

244

H29

ICPC

Ear symptom/complaint other

1.5

33.3

1211

8458

R03BC01

ATC

cromoglicic acid; inhalant

2.7

33.3

176

652

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.2

33.0

282

1300

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

32.9

3098

25237

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

32.9

1304

9262

U13

ICPC

Bladder symptom/complaint other

2.1

32.9

334

1647

3AX01, ,

NOMESCO Finland

5.1

32.8

137

N19

ICPC

Speech disorder

3.1

32.6

136

442

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

32.6

734

4609

WX320

NOMESCO Finland

Spinalanesthesy

1.3

32.5

2609

20791

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

32.4

743

4685

A06AD11

ATC

lactulose; oral

1.4

32.4

1412

10205

L04

ICPC

Chest symptom/complaint

1.7

32.3

669

4111

C10AA05

ATC

atorvastatin; oral

1.3

32.3

4326

36820

N02BF02

ATC

pregabalin; oral

1.7

32.3

627

3788

L05

ICPC

Flank/axilla symptom/complaint

1.7

32.3

640

3890

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

32.2

344

1728

J39.8

ICD-10 Finland

Other specified diseases of upper respiratory tract

4.8

32.1

151

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

32.1

2308

18101

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.2

32.0

285

1336

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

31.9

827

5369

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

31.9

589

3511

M02AA10

ATC

ketoprofen; topical

1.4

31.8

1695

12685

K58

ICD-10 Finland

Irritable bowel syndrome

2.1

31.7

288

1361

Z00.0

ICD-10 Finland

General medical examination

1.4

31.7

1995

15332

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

31.5

738

4680

L29

ICPC

Musculoskeletal sympt/complt other

1.5

31.2

915

6107

J04

ICD-10 Finland

Acute laryngitis and tracheitis

3.7

31.2

266

R09

ICPC

Sinus symptom/complaint

1.5

31.2

879

5817

WX734

NOMESCO Finland

JET-ventilation

8.2

31.2

M03BX01

ATC

baclofen; systemic

2.4

31.1

213

894

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

31.1

10703

101693

-1, ,

NOMESCO Finland

1.3

31.1

3454

28709

J35.0

ICD-10 Finland

Chronic tonsillitis

1.8

31.0

512

2959

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

31.0

1037

7119

WX290

NOMESCO Finland

Other blockage of nerve

1.3

30.9

4913

42593

R11

ICD-10 Finland

Nausea and vomiting

1.5

30.9

871

5765

ZXC60

NOMESCO Finland

Application of heat

2.6

30.8

179

695

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.0

30.8

340

1727

E000001, ,

ATC

1.3

30.8

2067

16034

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

30.7

726

4614

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

30.6

746

4774

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

30.6

1147

8054

WX892

NOMESCO Finland

Monitored bed care

1.6

30.5

735

4692

SFA30

NOMESCO Finland

Three-surface restoration

1.3

30.3

4586

39509

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

5.9

30.3

N39.3

ICD-10 Finland

Stress incontinence

1.5

30.3

858

5683

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

30.2

1604

11986

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.0

30.0

348

1799

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.6

29.8

651

4056

N30.0

ICD-10 Finland

Acute cystitis

1.4

29.8

1776

13523

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.9

29.6

386

2075

U05

ICPC

Urination problems other

1.7

29.6

511

2991

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

29.5

576

3485

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

29.5

1343

9774

J01

ICD-10 Finland

Acute sinusitis

1.7

29.4

584

3550

B37.0

ICD-10 Finland

Candidal stomatitis

2.8

29.4

143

507

J01DA08

ATC

[U] cefaclor

1.5

29.4

1036

7186

D07AB08

ATC

desonide; topical

1.5

29.3

1106

7771

S01GX02

ATC

levocabastine; ophthalmic

1.6

29.3

622

3848

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.8

29.2

415

2292

N05BA12

ATC

alprazolam; oral

1.5

29.1

1043

7255

C10AC01

ATC

colestyramine; oral

2.0

29.1

310

1555

R15

ICD-10 Finland

Faecal incontinence

2.0

29.1

322

1638

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.5

29.0

934

6357

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

29.0

513

3023

M01AB55

ATC

diclofenac, combinations; oral

1.6

29.0

694

4423

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

28.8

356

1880

R01AD59

ATC

mometasone, combinations; nasal

1.8

28.8

412

2282

D01AE16

ATC

amorolfine; topical

1.4

28.6

1214

8719

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.3

28.6

217

954

XA800

NOMESCO Finland

Neuropsychological investigation

1.8

28.5

404

2230

C01DA14

ATC

isosorbide mononitrate; oral

1.4

28.5

1370

10060

A29

ICPC

General symptom/complaint other

1.4

28.5

1272

9220

K04

ICPC

Palpitations/awareness of heart

1.7

28.4

565

3435

D06BB03

ATC

aciclovir; topical

1.7

28.4

512

3033

S16

ICPC

Bruise/contusion

2.0

28.3

321

1647

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

28.2

429

2420

SAA04

NOMESCO Finland

Special examination of mouth

1.7

28.1

535

3215

7844L

ICD-9 Finland

Symptoms involving head and neck, Voice disturbance[RINOPHONIA SEU RHINOLALIA]

+∞

28.1

7844C

ICD-9 Finland

Symptoms involving head and neck, Voice disturbance[DYSPHONIA FUNCTIONALIS ALIA]

+∞

28.1

R25.2

ICD-10 Finland

Cramp and spasm

2.1

28.1

265

1271

J39.9

ICD-10 Finland

Disease of upper respiratory tract, unspecified

3.6

28.1

257

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

28.0

451

2588

L86

ICPC

Back syndrome with radiating pain

1.6

27.9

642

4050

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

4.6

27.9

145

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

27.9

1056

7424

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

27.8

2399

19253

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.8

27.7

396

2191

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

27.7

844

5679

UJD10, ,

SPAT

2.1

27.6

252

1194

D21

ICPC

Swallowing problem

2.6

27.6

158

610

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

27.6

775

5123

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

27.5

899

6136

VALMI, ,

NOMESCO Finland

1.3

27.5

2502

20215

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

27.5

722

4700

P03

ICPC

Feeling depressed

1.5

27.5

930

6394

P01

ICPC

Feeling anxious/nervous/tense

1.4

27.3

1089

7729

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.9

27.3

328

1716

R52.0

ICD-10 Finland

Acute pain

1.9

27.3

341

1808

R5110, ,

SPAT

1.6

27.3

671

4302

R1250

NOMESCO Finland

Evaluation of functional capability

2.2

27.2

239

1115

K03.80

ICD-10 Finland

Irradiated enamel

1.7

27.1

563

3462

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

27.1

644

4097

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.9

27.0

364

1978

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.1

26.9

252

1206

SBB10

NOMESCO Finland

Dental impressions

1.6

26.9

632

4008

M05BA04

ATC

alendronic acid; oral

1.5

26.9

875

5967

G25.0

ICD-10 Finland

Essential tremor

2.0

26.8

275

1361

UJC12

NOMESCO Finland

Flexible oesophagoscopy

3.3

26.8

101

309

J01FA01

ATC

erythromycin; systemic

1.4

26.8

1391

10343

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.0

26.8

303

1554

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.6

26.8

667

4290

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

26.7

7547

69144

S22

ICPC

Nail symptom/complaint

1.6

26.6

644

4114

J06.0

ICD-10 Finland

Acute laryngopharyngitis

3.0

26.6

117

393

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

26.6

1184

8576

J01AA07

ATC

tetracycline; systemic

1.4

26.4

1496

11279

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

26.4

497

2978

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

26.4

2309

18547

D01BA02

ATC

terbinafine; oral

1.3

26.4

2554

20786

A02BA04

ATC

nizatidine; systemic

1.5

26.4

755

5010

N03AX09

ATC

lamotrigine; oral

1.7

26.3

463

2724

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

3.5

26.3

264

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

26.2

754

5009

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

26.2

1100

7882

U01

ICPC

Dysuria/painful urination

1.5

26.2

824

5581

N06AX26

ATC

vortioxetine; oral

1.6

26.0

699

4573

H01.0

ICD-10 Finland

Blepharitis

1.6

26.0

665

4302

M02AA15

ATC

diclofenac; topical

1.5

26.0

746

4954

EB1SA, ,

SPAT

1.7

25.9

542

3341

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.9

25.9

304

1580

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

25.8

476

2838

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

25.8

1283

9470

L20.0

ICD-10 Finland

Besnier prurigo

1.6

25.8

677

4407

M01AC01

ATC

piroxicam; systemic, rectal

1.4

25.7

1338

9950

T86

ICPC

Hypothyroidism/myxoedema

1.7

25.7

460

2721

M77.4

ICD-10 Finland

Metatarsalgia

1.6

25.6

639

4110

WX110, ,

SPAT

1.6

25.6

590

3725

A99

ICPC

Disease/condition unspecnature/site

1.5

25.6

926

6452

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

25.5

460

2725

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

25.5

1290

9549

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

25.4

602

3827

E000002, ,

ATC

1.4

25.3

1095

7885

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

25.3

734

4884

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

25.3

486

2929

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

25.3

2522

20591

J01DA09

ATC

[U] cefadroxil

1.3

25.1

2775

22936

L95

ICPC

Osteoporosis

1.8

25.1

390

2214

R04

ICPC

Breathing problem other

1.8

25.1

384

2170

J31.2

ICD-10 Finland

Chronic pharyngitis

3.3

25.1

277

E03

ICD-10 Finland

Other hypothyroidism

1.6

25.1

657

4274

N02CC04

ATC

rizatriptan; oral

1.6

25.1

599

3814

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

25.1

298

1555

L50.9

ICD-10 Finland

Urticaria, unspecified

1.8

25.0

390

2217

G43.3

ICD-10 Finland

Complicated migraine

2.3

25.0

187

818

Z2445

NOMESCO Finland

Psychologist

1.8

25.0

363

2021

J01AA04

ATC

lymecycline; systemic

1.4

24.9

1301

9677

K29.7

ICD-10 Finland

Gastritis, unspecified

1.8

24.9

369

2066

R05DA01

ATC

ethylmorphine; oral

1.5

24.9

814

5556

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

24.9

927

6493

XG466

NOMESCO Finland

Sleep oxymetry

1.9

24.8

300

1574

SFA00

NOMESCO Finland

Small restoration

1.4

24.8

1417

10695

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.8

24.8

372

2091

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

24.8

339

1852

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.9

24.7

303

1597

J39.2

ICD-10 Finland

Other diseases of pharynx

2.9

24.7

113

388

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.8

24.7

347

1911

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

24.6

1963

15556

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

24.6

2494

20390

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.0

24.6

256

1275

N06AB06

ATC

sertraline; oral

1.4

24.6

1111

8062

N05CD07

ATC

temazepam; oral

1.4

24.6

1102

7987

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

2.9

24.5

112

385

G04CB01

ATC

finasteride; oral

1.5

24.3

856

5930

RD210, ,

NOMESCO Finland

2.3

24.3

185

815

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.3

24.2

191

854

N02CC03

ATC

zolmitriptan; nasal, oral

1.6

24.2

572

3632

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

24.1

2156

17346

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

24.1

1178

8665

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

24.1

1560

12000

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.1

24.1

237

1157

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

24.0

829

5721

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

23.9

1866

14742

R05DA09

ATC

dextromethorphan; oral

2.3

23.8

177

772

G01AF05

ATC

econazole; vaginal

1.5

23.8

879

6146

QA1S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head

4.1

23.7

156

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.2

23.7

197

900

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

23.7

770

5248

R51.81

ICD-10 Finland

Facial pain NOS

2.0

23.7

259

1314

R04.0

ICD-10 Finland

Epistaxis

1.5

23.6

702

4695

Z00.8

ICD-10 Finland

Other general examinations

1.5

23.6

761

5178

L20

ICPC

Joint symptom/complaint NOS

1.7

23.5

392

2272

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.7

23.5

419

2475

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.7

23.5

415

2445

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

23.5

918

6487

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

4.0

23.5

166

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.3

23.5

264

1430

FHL

Laryngoscopy (direct)

7.8

23.4

UDM02

NOMESCO Finland

Sinoscopy

2.1

23.3

229

1118

R4110, ,

SPAT

1.5

23.3

884

6214

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.1

23.2

209

986

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.7

23.1

460

2799

SPAT1260

SPAT

Consultation of another employee

1.3

23.1

1790

14119

SPAT1153

SPAT

Removal of sutures

1.2

23.1

3288

27931

D82

ICPC

Teeth/gum disease

1.2

23.1

3816

32933

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

23.0

940

6697

G04BD11

ATC

fesoterodine; oral

1.9

23.0

295

1579

RL120, ,

NOMESCO Finland

24.7

23.0

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

23.0

1309

9869

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.7

22.9

196

K03.00

ICD-10 Finland

Approximal wear

1.5

22.9

674

4501

EMB10

NOMESCO Finland

Tonsillectomy

1.6

22.8

497

3096

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

22.8

1477

11357

H02AB09

ATC

hydrocortisone; systemic

2.0

22.7

242

1216

EP1AE, ,

SPAT

2.1

22.7

208

988

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

22.7

585

3793

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

22.7

1726

13580

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

22.6

2572

21299

R4130, ,

SPAT

5.9

22.6

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.7

22.5

423

2534

R25.1

ICD-10 Finland

Tremor, unspecified

1.8

22.5

315

1733

G24.9

ICD-10 Finland

Dystonia, unspecified

4.3

22.4

133

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.5

22.3

770

5311

L19

ICPC

Muscle symptom/complaint NOS

1.9

22.3

286

1531

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.1

22.3

223

1096

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

22.2

564

3642

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

22.2

661

4422

4CJ01, ,

NOMESCO Finland

5.5

22.2

L11

ICPC

Wrist symptom/complaint

1.4

22.1

888

6304

SPAT1301

SPAT

No procedures

1.2

22.1

3228

27468

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

22.1

252

1298

B01AB05

ATC

enoxaparin; parenteral

1.2

22.0

3335

28492

C08DA01

ATC

verapamil; systemic

1.7

21.8

391

2314

D07AD01

ATC

clobetasol; topical

1.3

21.8

1716

13556

C10AX09

ATC

ezetimibe; oral

1.3

21.8

1484

11488

N76.0

ICD-10 Finland

Acute vaginitis

1.5

21.6

598

3937

4760A

ICD-9 Finland

Chronic laryngitis and laryngotracheitis, Chronic laryngitis

6.0

21.6

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.0

21.6

220

1088

N30

ICD-10 Finland

Cystitis

1.4

21.6

839

5923

A02BA03

ATC

famotidine; systemic

1.8

21.5

352

2030

S22.3

ICD-10 Finland

Fracture of rib

1.5

21.5

635

4241

R07

ICPC

Sneezing/nasal congestion

1.5

21.4

616

4092

P01BA02

ATC

hydroxychloroquine; oral

1.4

21.4

865

6150

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

21.3

699

4771

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

21.3

1084

8019

S08

ICPC

Skin colour change

1.6

21.3

531

3415

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

21.3

283

1533

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

21.3

530

3408

G47.8

ICD-10 Finland

Other sleep disorders

2.4

21.3

150

640

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

21.2

658

4443

G01AA10

ATC

clindamycin; vaginal

1.3

21.1

1612

12680

M54.8

ICD-10 Finland

Other dorsalgia

1.6

21.1

447

2765

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.6

21.0

472

2963

F01

ICPC

Eye pain

1.8

20.9

287

1570

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

2.0

20.9

215

1067

SPAT1263

SPAT

Sampling

1.2

20.9

4431

39089

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.2

20.9

171

777

S12

ICPC

Insect bite/sting

1.4

20.9

835

5922

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

20.9

498

3169

SPAT1043

SPAT

Audiometry

1.4

20.9

988

7220

8070/3-C32.0

ICD-O-3

Squamous cell carcinoma, NOS, of glottis

6.4

20.9

A01AB10

ATC

natamycin; local oral

1.8

20.9

291

1601

A28

ICPC

Limited function/disability NOS

1.3

20.8

1577

12386

S01GX05

ATC

lodoxamide; ophthalmic

2.3

20.8

152

659

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.9

20.7

268

1439

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

20.7

408

2476

R77

ICPC

Laryngitis/tracheitis acute

4.1

20.7

133

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

20.6

920

6659

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.4

20.6

836

5949

Z57.3

ICD-10 Finland

Occupational exposure to other air contaminants

3.9

20.5

151

M54.1

ICD-10 Finland

Radiculopathy

1.7

20.5

405

2460

R01AC01

ATC

cromoglicic acid; nasal

1.7

20.4

361

2129

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.6

20.4

119

465

A60

ICPC

General and Unspecified, Result test/procedure

1.6

20.3

429

2650

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

2.4

20.3

137

573

UJC02

NOMESCO Finland

Rigid oesophagoscopy

2.9

20.3

331

ZY010

NOMESCO Finland

Hospital outpatient

1.6

20.3

455

2855

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

20.2

805

5707

TQW99

NOMESCO Finland

Other minor procedure on skin

1.6

20.1

488

3119

D02AE01

ATC

carbamide; topical

1.5

20.1

627

4236

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.5

20.1

553

3638

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.6

20.1

491

3145

XQ802

NOMESCO Finland

Epicutan test

1.7

20.0

411

2522

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

20.0

443

2770

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.9

20.0

238

1244

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

20.0

766

5391

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.7

20.0

363

2157

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.8

19.9

306

1734

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.2

19.9

159

716

N29

ICPC

Neurological sympt/complt other

2.1

19.9

191

925

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

19.9

500

3223

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

19.9

1277

9795

H10.4

ICD-10 Finland

Chronic conjunctivitis

2.6

19.9

110

419

SPAT1040

SPAT

Nasolaryngoscopy

4.4

19.8

112

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.0

19.8

199

981

R01AX03

ATC

ipratropium bromide; nasal

2.0

19.7

212

1070

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

19.7

491

3159

C03CA01

ATC

furosemide; systemic

1.2

19.7

2808

23786

S01

ICPC

Pain/tenderness of skin

1.6

19.7

443

2782

E000006, ,

ATC

1.5

19.6

684

4726

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

19.6

876

6337

S02.51

ICD-10 Finland

Fracture of tooth, open

1.4

19.6

960

7057

M65.3

ICD-10 Finland

Trigger finger

1.6

19.6

473

3021

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.6

19.5

113

440

WX290, ,

SPAT

1.7

19.4

333

1947

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.6

19.4

477

3058

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.9

19.4

261

1420

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

2.5

19.4

117

465

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.5

19.4

119

477

G12.2

ICD-10 Finland

Motor neuron disease

3.8

19.4

153

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

2.7

19.4

105

396

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.4

19.3

977

7222

G54.0

ICD-10 Finland

Brachial plexus disorders

1.9

19.2

259

1410

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

1.9

19.2

254

1375

A08

ICPC

Swelling

1.6

19.2

492

3186

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

19.2

1489

11729

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

19.2

2729

23103

R5599

NOMESCO Finland

Other rehabilitation service

1.8

19.2

270

1491

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

19.0

522

3432

R30.0

ICD-10 Finland

Dysuria

1.6

19.0

400

2470

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.8

19.0

289

1633

N07CA01

ATC

betahistine; oral

1.5

19.0

707

4949

DM1QA, ,

SPAT

1.7

18.9

335

1977

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

18.9

609

4142

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.7

18.9

349

2083

XKC03

NOMESCO Finland

Water cystometry

1.8

18.9

300

1717

SPAT1059

SPAT

Spirometry at the office

1.6

18.9

491

3190

H02.3

ICD-10 Finland

Blepharochalasis

1.5

18.9

660

4564

I84

ICD-10 Finland

Hemorrhoids

1.8

18.8

270

1499

ZXD05

NOMESCO Finland

Urgent procedure

1.2

18.8

3047

26133

C03DA01

ATC

spironolactone; oral

1.4

18.8

1082

8163

D06AX01

ATC

fusidic acid; topical

1.4

18.8

873

6361

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

18.7

896

6558

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

3.2

18.7

224

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.6

18.7

460

2949

R4190

NOMESCO Finland

Nutritional therapy

1.7

18.7

338

2006

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

18.7

435

2754

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

18.7

554

3704

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.4

18.7

979

7275

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

18.6

368

2237

L50.3

ICD-10 Finland

Dermatographic urticaria

2.1

18.6

179

868

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.5

18.6

602

4101

R60.9

ICD-10 Finland

Oedema, unspecified

1.5

18.6

537

3572

Z31.5

ICD-10 Finland

Genetic counselling

1.5

18.5

510

3358

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.2

18.5

153

700

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

18.4

1878

15307

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.8

18.3

280

1586

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

18.3

684

4792

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.6

18.2

386

2388

N06AG02

ATC

moclobemide; oral

1.6

18.2

411

2583

N06AX22

ATC

agomelatine; oral

1.9

18.2

211

1095

P20

ICPC

Memory disturbance

1.3

18.1

1208

9309

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.6

18.1

469

3044

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

2.5

18.1

110

439

4700A

ICD-9 Finland

Deflected nasal septum[DEFORMATIO SEPTI NASI]

2.3

18.1

131

567

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

1.8

18.0

279

1585

D02AX

ATC

Other emollients and protectives

1.7

18.0

297

1719

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.2

18.0

156

727

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.6

18.0

385

2389

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.6

18.0

382

2366

S01AA01

ATC

chloramphenicol; ophthalmic

1.6

17.9

469

3051

PA6AD

NOMESCO Finland

CT of neck arteries

1.8

17.9

273

1544

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

17.9

2776

23680

J01CA08

ATC

pivmecillinam; oral

1.2

17.9

4618

41302

R01BA01

ATC

phenylpropanolamine; oral

1.5

17.9

522

3479

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.2

17.9

152

703

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1.6

17.9

367

2254

R31

ICD-10 Finland

Unspecified haematuria

1.4

17.8

869

6382

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

4.2

17.8

109

U71

ICPC

Cystitis/urinary infection other

1.4

17.7

674

4736

J31.1

ICD-10 Finland

Chronic nasopharyngitis

2.6

17.7

368

H02BX01

ATC

methylprednisolone, combinations; systemic

1.6

17.7

471

3076

SPAT1057

SPAT

Peak expiratory flow measurement

1.9

17.7

222

1182

M01AX01

ATC

nabumetone; oral

1.6

17.7

408

2578

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

17.7

599

4117

Z02.7

ICD-10 Finland

Issue of medical certificate

1.5

17.6

649

4532

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

17.6

1103

8425

G03DB01

ATC

dydrogesterone; oral

1.3

17.5

1358

10691

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

17.5

1076

8198

D22

ICD-10 Finland

Melanocytic naevi

1.5

17.4

492

3255

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

5.2

17.4

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.8

17.4

238

1302

C01BC04

ATC

flecainide; systemic

1.7

17.4

318

1893

SPAT1336

SPAT

Request for examination

1.7

17.4

347

2114

J01MA01

ATC

ofloxacin; systemic

1.4

17.4

745

5350

N41.1

ICD-10 Finland

Chronic prostatitis

2.0

17.4

174

857

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

17.4

628

4371

N03AX11

ATC

topiramate; oral

1.8

17.3

241

1326

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.3

17.3

1304

10219

M03AX01

ATC

botulinum toxin; parenteral

2.3

17.3

131

578

H81.3

ICD-10 Finland

Other peripheral vertigo

1.8

17.3

275

1576

G47.9

ICD-10 Finland

Sleep disorder, unspecified

1.8

17.2

255

1430

H10

ICD-10 Finland

Conjunctivitis

1.4

17.2

671

4736

G43.8

ICD-10 Finland

Other migraine

2.1

17.2

152

714

A91

ICPC

Abnormal result investigation NOS

1.6

17.2

453

2952

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.4

17.2

813

5939

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

17.2

2978

25670

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.5

17.2

632

4415

A02BX02

ATC

sucralfate; oral

1.6

17.1

359

2216

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.6

17.1

433

2796

D07XC01

ATC

betamethasone; topical

1.3

17.1

1118

8590

RK110, ,

NOMESCO Finland

2.8

17.1

307

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

1.5

17.1

474

3126

B35.1

ICD-10 Finland

Tinea unguium

1.5

17.0

594

4108

S01GX08

ATC

ketotifen; ophthalmic

1.6

17.0

412

2636

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.2

16.9

133

596

R03AC19

ATC

olodaterol

3.6

16.9

154

J38

ICD-10 Finland

Diseases of vocal cords and larynx, not elsewhere classified

17.4

16.9

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

16.8

1516

12160

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.0

16.8

188

963

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

16.8

520

3508

G04BD09

ATC

trospium; oral

1.8

16.8

242

1346

B02AA02

ATC

tranexamic acid; systemic

1.3

16.8

1574

12687

D25

ICPC

Abdominal distension

2.0

16.8

190

978

B37.08

ICD-10 Finland

Other candidal stomatitis

2.6

16.7

373

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.3

16.7

118

505

A92

ICPC

Allergy/allergic reaction NOS

1.8

16.7

270

1554

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.6

16.7

441

2877

7844X

ICD-9 Finland

Symptoms involving head and neck, Voice disturbance[APHONIA SEU DYSPHONIA ALIA SEU NUD]

+∞

16.7

R75

ICPC

Sinusitis acute/chronic

1.5

16.7

468

3094

R41.3

ICD-10 Finland

Other amnesia

1.8

16.7

265

1519

M76.6

ICD-10 Finland

Achilles tendinitis

1.5

16.6

468

3095

WX723

NOMESCO Finland

CPAP therapy

1.6

16.6

361

2249

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.4

16.6

107

440

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

4.8

16.5

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.1

16.5

162

792

M54.3

ICD-10 Finland

Sciatica

1.5

16.5

590

4097

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.6

16.5

376

2369

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.7

16.5

301

1792

M15

ICD-10 Finland

Polyarthrosis

1.5

16.5

497

3335

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

16.5

203

1075

TQW40, ,

SPAT

1.4

16.5

690

4935

A27

ICPC

Fear of other disease NOS

1.5

16.5

457

3014

R5120

NOMESCO Finland

Preparation of an aid

1.8

16.4

258

1473

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.5

16.4

557

3830

EB1VA, ,

NOMESCO Finland

1.3

16.4

1195

9322

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

16.4

899

6727

M35.7

ICD-10 Finland

Hypermobility syndrome

2.2

16.4

143

669

W19

ICD-10 Finland

Unspecified fall

1.4

16.4

878

6546

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

16.4

2183

18314

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.1

16.4

146

689

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

16.3

738

5350

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.6

16.3

341

2104

M75.8

ICD-10 Finland

Other shoulder lesions

1.6

16.3

363

2277

S20.2

ICD-10 Finland

Contusion of thorax

1.5

16.2

459

3039

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.6

16.2

411

2656

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.8

16.2

222

1217

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

16.2

541

3709

X15

ICPC

Vaginal symptom/complaint other

1.6

16.2

340

2101

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.4

16.2

801

5897

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

1.8

16.1

234

1305

TGC00

NOMESCO Finland

Bronchial lavation

1.8

16.1

230

1276

H13

ICPC

Plugged feeling ear

1.2

16.1

1827

15057

F16

ICPC

Eyelid symptom/complaint

1.5

16.1

479

3208

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.3

16.1

1021

7812

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

1.9

16.0

192

1008

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

16.0

493

3324

SXC05

NOMESCO Finland

Other oral or dental procedure

1.5

16.0

589

4115

B01AC04

ATC

clopidogrel; oral

1.3

16.0

1403

11215

Z58.8

ICD-10 Finland

Other problems related to physical environment

5.1

16.0

N81.6

ICD-10 Finland

Rectocele

1.4

15.9

688

4948

D10AX03

ATC

azelaic acid; topical

1.4

15.9

616

4344

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.6

15.9

407

2637

J02

ICD-10 Finland

Acute pharyngitis

1.7

15.8

287

1707

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.0

15.8

161

799

N02CC05

ATC

almotriptan; oral

1.6

15.8

382

2443

A05

ICPC

Feeling ill

1.5

15.8

502

3409

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

15.7

551

3813

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.4

15.7

591

4145

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

15.7

1092

8462

4239

FHL

Other measure in this category

3.3

15.7

172

R30.1

ICD-10 Finland

Vesical tenesmus

1.9

15.6

206

1116

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.6

15.6

393

2536

M05BA07

ATC

risedronic acid; oral

1.7

15.6

290

1736

G03FA01

ATC

norethisterone and estrogen; systemic

1.3

15.6

1407

11284

M05BX04

ATC

denosumab; parenteral

1.5

15.6

570

3978

R06.4

ICD-10 Finland

Hyperventilation

2.0

15.6

155

763

TEA00

NOMESCO Finland

Biopsy of lip

2.4

15.6

104

435

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

1.8

15.5

212

1161

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.0

15.5

154

757

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

2.4

15.5

108

460

A09

ICPC

Sweating problem

2.3

15.5

118

523

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

2.5

15.5

394

C10AA03

ATC

pravastatin; oral

1.4

15.4

636

4537

N02AA05

ATC

oxycodone; systemic

1.3

15.4

1610

13139

S01XA18

ATC

ciclosporin; ophthalmic

2.6

15.4

325

N06AX03

ATC

mianserin; oral

1.5

15.3

441

2931

K29

ICPC

Cardiovascular sympt/complt other

1.6

15.3

390

2523

WX780

NOMESCO Finland

Remote monitoring CPAP

1.6

15.3

374

2397

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

2.2

15.3

128

589

AN1

Coronary angiography

1.3

15.3

928

7050

SPAT1097

SPAT

Recording of ECG

1.3

15.3

1389

11148

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.7

15.3

270

1595

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

15.3

1394

11194

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.7

15.2

295

1786

G04CB02

ATC

dutasteride; oral

1.5

15.2

550

3831

TKC20

NOMESCO Finland

Catheterisation of bladder

1.4

15.2

584

4114

D04

ICPC

Rectal/anal pain

2.1

15.2

143

690

OAA80, ,

SPAT

0.6

15.1

282

4570

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

1.9

15.1

193

1035

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

15.1

2614

22482

SPAT1312

SPAT

General health counselling

1.2

15.1

3172

27767

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.8

15.1

205

1121

R03BB07

ATC

umeclidinium bromide; inhalant

2.5

15.1

351

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.5

15.1

554

3868

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

2.6

15.1

322

L60.0

ICD-10 Finland

Ingrowing nail

1.5

15.1

426

2821

J02AB02

ATC

ketoconazole; oral

1.7

15.1

268

1586

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.3

15.1

108

466

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

15.1

808

6024

R07.2

ICD-10 Finland

Precordial pain

1.9

15.1

197

1065

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

1.6

15.0

308

1892

J32.4

ICD-10 Finland

Chronic pansinusitis

2.1

15.0

142

686

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

15.0

685

4974

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

1.4

15.0

585

4132

RK120, ,

NOMESCO Finland

4.0

15.0

106

RS221, ,

NOMESCO Finland

2.1

15.0

133

627

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.4

15.0

644

4629

K05.1

ICD-10 Finland

Chronic gingivitis

1.4

14.9

641

4605

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.8

14.9

204

1119

F60.5

ICD-10 Finland

Anankastic personality disorder

2.3

14.9

110

481

R05DB05

ATC

pentoxyverine; oral, rectal

1.6

14.9

331

2075

A07EC01

ATC

sulfasalazine; oral, rectal

1.4

14.9

750

5536

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

1.9

14.9

194

1048

F34.1

ICD-10 Finland

Dysthymia

1.6

14.9

321

1998

ZXD35

NOMESCO Finland

Usual procedure

1.7

14.8

290

1760

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

14.8

4056

36291

SPAT1254

SPAT

Administration of medicine

1.3

14.8

1342

10765

F80.1

ICD-10 Finland

Expressive language disorder

2.8

14.8

263

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

14.8

388

2528

WW200

NOMESCO Finland

Immunization

1.7

14.8

242

1400

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

14.8

2997

26147

ACC51

NOMESCO Finland

Release of median nerve

1.4

14.8

734

5406

F03

ICPC

Eye discharge

1.4

14.7

609

4346

H91.1

ICD-10 Finland

Presbycusis

1.5

14.7

532

3703

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

14.7

1081

8439

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.6

14.7

376

2436

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

2.0

14.7

148

732

H26.4

ICD-10 Finland

After-cataract

1.3

14.7

900

6849

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.5

14.6

440

2953

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.7

14.6

242

1405

-, ,

ICD-10 Finland

1.8

14.6

210

1170

G20

ICD-10 Finland

Parkinson disease

1.7

14.6

270

1616

J01DC04

ATC

cefaclor; oral

2.2

14.6

119

543

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

14.6

732

5402

K11.2

ICD-10 Finland

Sialoadenitis

1.6

14.5

318

1986

SCA02

NOMESCO Finland

Preventive oral health care

1.3

14.5

904

6894

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

14.5

731

5396

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.4

14.5

593

4224

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.8

14.5

223

1267

K20

ICD-10 Finland

Oesophagitis

2.0

14.5

157

797

G25.2

ICD-10 Finland

Other specified forms of tremor

2.8

14.5

244

N28

ICPC

Limited function/disability (N)

2.0

14.5

150

750

M70.7

ICD-10 Finland

Other bursitis of hip

1.7

14.5

256

1514

F64.0

ICD-10 Finland

Transsexualism

6.6

14.5

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

2.2

14.4

116

526

N02CC06

ATC

eletriptan; oral

1.6

14.4

335

2123

N06AX12

ATC

bupropion; oral

1.4

14.4

598

4272

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

1.7

14.4

240

1396

N03AF01

ATC

carbamazepine; oral, rectal

1.5

14.4

436

2932

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

1.9

14.4

170

890

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.5

14.3

382

2498

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.7

14.3

261

1555

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.5

14.3

465

3170

I49.1

ICD-10 Finland

Atrial premature depolarization

1.6

14.3

344

2197

G57.6

ICD-10 Finland

Lesion of plantar nerve

1.8

14.3

214

1206

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

14.3

709

5220

E000007, ,

ATC

1.5

14.3

498

3443

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.8

14.3

226

1295

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.4

14.3

597

4270

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.5

14.3

506

3511

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.7

14.2

280

1703

R06AX18

ATC

acrivastine; oral

1.7

14.2

267

1604

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.7

14.2

236

1371

R03CC02

ATC

salbutamol; systemic

1.5

14.2

379

2479

J31

ICD-10 Finland

Chronic rhinitis, nasopharyngitis and pharyngitis

2.3

14.2

110

491

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.5

14.2

428

2874

D01AC03

ATC

econazole; topical

1.4

14.2

529

3705

EB1WA, ,

NOMESCO Finland

2.8

14.2

236

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

14.2

689

5056

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.5

14.2

469

3210

B02.9

ICD-10 Finland

Zoster without complication

1.4

14.2

610

4385

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.5

14.2

430

2892

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

2.2

14.2

116

530

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

14.2

1172

9293

F64.9

ICD-10 Finland

Gender identity disorder, unspecified

5.3

14.2

G50.0

ICD-10 Finland

Trigeminal neuralgia

1.9

14.1

176

937

OAA65, ,

SPAT

1.3

14.1

1424

11566

D06BB10

ATC

imiquimod; topical

1.5

14.1

463

3164

JAH01

NOMESCO Finland

Laparoscopy

1.5

14.1

438

2960

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

2.2

14.1

118

544

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.6

14.1

308

1924

R68.81

ICD-10 Finland

A constant or recurrent sensitivity to experience symptoms and signs in relation to common factors in the environment, not elsewhere classified.

6.4

14.1

K07.68

ICD-10 Finland

Other disorders of the jaw joint

2.6

14.1

322

XJC00

NOMESCO Finland

Oesophageal manometry

3.4

14.1

144

SPAT1310

SPAT

Counselling related to known health issue

1.2

14.1

3169

27882

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

2.5

14.0

364

K07.61

ICD-10 Finland

Cracking jaw joint

1.9

14.0

185

1004

M01AH03

ATC

valdecoxib; oral

1.4

14.0

570

4058

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

1.9

14.0

176

941

M89.0

ICD-10 Finland

Algoneurodystrophy

2.4

14.0

389

N99

ICPC

Neurological disease other

2.2

14.0

115

527

L88

ICPC

Rheumatoid/seropositive arthritis

1.5

13.9

391

2587

M43.1

ICD-10 Finland

Spondylolisthesis

1.5

13.9

382

2515

Z51.6

ICD-10 Finland

Desensitization to allergens

2.3

13.9

102

445

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

13.9

1056

8279

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.8

13.9

218

1247

L18

ICPC

Muscle pain

1.5

13.8

376

2470

G04BD07

ATC

tolterodine; oral

1.5

13.8

425

2868

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.8

13.8

219

1257

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

1.6

13.8

358

2329

L04AX01

ATC

azathioprine; systemic

1.5

13.8

379

2497

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

1.7

13.7

268

1627

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

4.6

13.7

F44.4

ICD-10 Finland

Dissociative motor disorders

6.2

13.7

8070/3-C32.9

ICD-O-3

Squamous cell carcinoma, NOS, of larynx, NOS

6.2

13.7

N06BA04

ATC

methylphenidate; oral

1.7

13.7

222

1281

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

2.6

13.7

303

S15

ICPC

Foreign body in skin

1.4

13.7

580

4160

B01AB04

ATC

dalteparin; parenteral

1.5

13.7

487

3383

R33

ICD-10 Finland

Retention of urine

1.4

13.6

614

4449

L01BA01

ATC

methotrexate; systemic

1.6

13.6

346

2240

SPAT1283

SPAT

Restricted health certificate

1.2

13.6

1532

12600

K85

ICPC

Elevated blood pressure

1.2

13.6

1533

12610

R43

ICPC

Respiratory, Other diagnostic procedure

2.5

13.6

316

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.2

13.6

108

488

7844A

ICD-9 Finland

Symptoms involving head and neck, Voice disturbance[DYSPHONIA HYPERFUNCTIONALIS]

+∞

13.5

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.5

13.5

436

2969

C09CA01

ATC

losartan; oral

1.2

13.5

2473

21352

UGB02

NOMESCO Finland

Tracheoscopy

4.6

13.5

EBA05, ,

SPAT

1.9

13.5

159

832

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

13.5

2051

17405

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

1.8

13.5

194

1082

B977, D141,

ICD-10 Finland

140.2

13.4

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

1.9

13.4

165

875

SPAT1240

SPAT

Therapeutic discussion

1.3

13.4

924

7147

R06

ICD-10 Finland

Abnormalities of breathing

2.3

13.4

102

452

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

2.2

13.4

112

516

SGA05

NOMESCO Finland

Opening and preparing the root canals, extremely complicated And time consuming

1.4

13.4

524

3705

XJH00

NOMESCO Finland

Transanal ultrasonography

1.5

13.4

453

3116

EB1HA, ,

SPAT

1.9

13.4

170

912

C07AB02

ATC

metoprolol; systemic

1.2

13.4

1838

15439

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

1.9

13.4

153

793

K14.61

ICD-10 Finland

Glossodynia

2.4

13.3

379

K07

ICPC

Swollen ankles/oedema

1.5

13.3

404

2718

G43

ICD-10 Finland

Migraine

1.5

13.3

448

3079

A62

ICPC

General and Unspecified, Administrative procedure

1.7

13.3

224

1308

N62

ICD-10 Finland

Hypertrophy of breast

1.5

13.3

407

2744

G03CA04

ATC

estriol; systemic, vaginal

1.4

13.3

615

4478

K13.78

ICD-10 Finland

Other change in the oral mucosa

1.7

13.3

233

1376

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.5

13.2

379

2519

N89

ICPC

Migraine

1.6

13.2

280

1738

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.4

13.2

693

5152

J37.1

ICD-10 Finland

Chronic laryngotracheitis

9.6

13.2

N64.4

ICD-10 Finland

Mastodynia

1.6

13.2

311

1980

PD5BD

NOMESCO Finland

Extensive CT of aorta

1.9

13.2

153

797

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

2.4

13.2

357

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.0

13.1

134

667

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

3.6

13.1

117

M09AX01

ATC

hyaluronic acid; parenteral

1.5

13.1

423

2884

C10AA01

ATC

simvastatin; oral

1.2

13.1

4036

36368

R08

ICPC

Nose symptom/complaint other

1.6

13.1

303

1921

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.7

13.0

237

1413

N94.1

ICD-10 Finland

Dyspareunia

2.1

13.0

115

542

C05AA01

ATC

hydrocortisone; rectal, topical

1.5

13.0

460

3190

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.6

13.0

306

1946

EMAK, ,

NOMESCO Finland

1.6

13.0

325

2096

H53.2

ICD-10 Finland

Diplopia

1.6

13.0

282

1759

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.6

13.0

331

2145

L10

ICPC

Elbow symptom/complaint

1.5

13.0

464

3227

N06AA12

ATC

doxepin; systemic

1.5

13.0

460

3194

B37.00

ICD-10 Finland

Acute pseudomembraneuous candidal stomatitis

3.8

12.9

104

H02.4

ICD-10 Finland

Ptosis of eyelid

1.6

12.9

265

1630

K60.2

ICD-10 Finland

Anal fissure, unspecified

1.9

12.9

156

823

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

12.9

1031

8137

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.8

12.9

183

1017

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

1.9

12.9

167

902

A07EA06

ATC

budesonide; oral, local oral

1.6

12.9

324

2094

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.5

12.8

383

2568

RL310, ,

NOMESCO Finland

50.0

12.8

WX203

NOMESCO Finland

Infraclavicular plexus blockade

1.7

12.8

217

1269

L84

ICD-10 Finland

Corns and callosities

1.6

12.8

310

1985

W10

ICD-10 Finland

Fall on and from stairs and steps

1.5

12.8

460

3201

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.4

12.8

578

4191

Angiography of the heart and coronary arteries

1.5

12.8

464

3235

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

1.8

12.7

173

948

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

2.4

12.7

332

ZX120

NOMESCO Finland

Intravenous

1.3

12.7

862

6653

B01AA03

ATC

warfarin; systemic

1.2

12.7

1605

13359

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

3.6

12.7

110

R10

ICD-10 Finland

Abdominal and pelvic pain

2.0

12.7

137

696

WZC30

NOMESCO Finland

Teaching

1.2

12.7

1492

12325

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.4

12.7

572

4147

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.5

12.6

447

3102

D01AC02

ATC

miconazole; topical

1.4

12.6

650

4816

G45.3

ICD-10 Finland

Amaurosis fugax

1.8

12.6

172

944

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.2

12.6

1523

12618

K59.01

ICD-10 Finland

Constipation outlet obstruction type

2.0

12.6

124

610

H03BB01

ATC

carbimazole; oral

1.5

12.5

391

2646

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.5

12.5

368

2460

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

2.1

12.5

114

544

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

1.8

12.5

186

1048

49300

ICD-8 Finland

Asthma, bronchiale

1.7

12.5

206

1196

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

2.6

12.5

276

R97

ICPC

Allergic rhinitis

1.9

12.5

154

819

-60

ICPC

Result test/procedure

1.4

12.5

528

3787

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.5

12.4

370

2481

M67.4

ICD-10 Finland

Ganglion

1.4

12.4

630

4657

4364

FHL

Pharyngeal tongue plastic

13.1

12.4

B07.9

ICD-10 Finland

Verruca simplex

1.6

12.4

310

2001

R14

ICD-10 Finland

Flatulence and related conditions

2.2

12.4

436

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

5.0

12.4

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

1.7

12.4

230

1380

N02AJ13

ATC

tramadol and paracetamol; systemic

1.7

12.4

205

1192

S03

ICPC

Warts

1.9

12.4

162

878

120

Kela drug reimbursment

Hypogammaglobulinaemia

4.3

12.4

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.7

12.4

204

1185

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.7

12.4

210

1230

M22.4

ICD-10 Finland

Chondromalacia patellae

1.6

12.4

267

1665

J33.0

ICD-10 Finland

Polyp of nasal cavity

1.7

12.4

240

1457

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.1

12.3

115

554

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.1

12.3

115

554

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.7

12.3

222

1321

K03.66

ICD-10 Finland

Tooth plaque

1.4

12.3

652

4853

R81

ICPC

Pneumonia

1.6

12.3

308

1989

H66

ICD-10 Finland

Suppurative and unspecified otitis media

1.7

12.3

208

1217

D01AE15

ATC

terbinafine; topical

1.4

12.3

592

4340

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.7

12.3

238

1444

R09.3

ICD-10 Finland

Abnormal sputum

2.3

12.3

375

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.5

12.2

427

2956

-1, ,

ICD-10 Finland

1.5

12.2

393

2677

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.3

12.2

754

5743

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.4

12.2

345

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.5

12.2

369

2483

N02CC07

ATC

frovatriptan; oral

1.5

12.2

366

2459

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.1

12.2

115

557

G01AF02

ATC

clotrimazole; vaginal

1.5

12.2

348

2314

NB1AT

NOMESCO Finland

Puncture of shoulder with ultrasound guidance

2.6

12.2

274

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.5

12.1

323

2114

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

12.1

641

4769

EB1MA

NOMESCO Finland

Cephalometry with X-ray

1.9

12.1

159

863

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.3

12.1

1118

8983

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.3

12.1

755

5761

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3013707) Erythrocyte sedimentation rate by Westergren method

9827

78985

2.14

257.73

5.0

4.1

11.15

12.36

mm/h

17.06

9250

73196

(3005322) IgE [Units/volume] in Serum or Plasma

1599

6568

2.64

252.26

1.5

1.3

151.33

226.45

u/ml

3.04

1493

6035

(3013115) Eosinophils [#/volume] in Blood

7417

54589

1.88

245.80

6.4

6.0

0.19

e9/l

0.70

6547

47877

(3001604) Monocytes [#/volume] in Blood

7191

52677

1.86

238.90

6.2

5.8

0.56

0.58

e9/l

8.79

6251

45564

(3006315) Basophils [#/volume] in Blood

7187

52822

1.85

234.23

6.2

5.8

0.04

e9/l

0.09

6238

45639

(3019198) Lymphocytes [#/volume] in Blood

7303

54192

1.83

227.95

6.2

5.9

1.88

1.93

e9/l

2.12

6499

47928

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10065

83311

2.06

218.78

5.3

4.1

14.76

14.74

pmol/l

0.31

9420

76109

(40760892) CBC W Ordered Manual Differential panel - Blood

6737

49651

1.77

206.25

6.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

7886

61138

1.78

199.62

8.7

9.1

3.97

4.07

e9/l

3.67

6922

53356

(3019069) Monocytes/100 leukocytes in Blood

6686

49709

1.74

193.31

6.6

6.3

8.44

8.50

1.03

6279

46467

(3006504) Eosinophils/100 leukocytes in Blood

6653

49431

1.74

192.47

6.4

6.0

2.88

2.85

0.46

6232

46113

(3018010) Neutrophils/100 leukocytes in Blood

6737

50280

1.74

191.32

6.3

5.9

56.82

57.16

1.62

6331

47048

(3002030) Lymphocytes/100 leukocytes in Blood

6813

51010

1.74

191.23

6.4

6.1

28.35

28.09

1.20

6406

47784

(3022096) Basophils/100 leukocytes in Blood

6463

47823

1.73

188.00

6.4

6.1

0.70

0.68

1.01

6029

44496

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6425

47489

1.73

187.43

6.3

5.8

1.21

mmol/l

0.03

5961

43252

(3018418) pH of Serum or Plasma

4623

31284

1.76

184.19

4.2

4.0

7.40

0.66

730

5994

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6925

52563

1.71

180.43

6.9

6.5

1.22

mmol/l

0.04

6027

44581

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

11191

98332

2.31

180.22

6.5

4.9

1.90

2.12

mu/l

1.37

10530

90462

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3088

18633

1.87

179.43

1.7

1.5

—

(40768797) Stomach Pathology biopsy report

2578

14799

1.93

173.83

1.2

—

(3000492) Spirometry study

1895

9874

2.08

167.53

1.6

1.5

—

(4200892) Spirometry reversibility

1561

7605

2.20

163.95

1.6

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9669

81589

1.81

162.38

8.0

7.5

75.82

78.00

u/l

5.23

9192

76925

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11661

105243

2.58

160.52

17.7

13.9

21.43

23.03

mg/l

6.13

9557

83325

(3007164) IgA [Mass/volume] in Serum or Plasma

3210

20348

1.78

154.97

1.5

2.25

2.38

g/l

2.67

1875

12270

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6157

46587

1.63

151.23

3.2

2.9

111.66

119.61

ug/l

0.99

5772

43181

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3590

23628

1.73

151.14

1.3

1.51

1.64

u/ml

0.25

887

6376

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5763

42938

1.63

150.34

2.1

2.0

98.35

96.83

pmol/l

1.48

2847

22005

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4445

31054

1.67

149.31

2.2

2.1

169.71

200.09

u/l

1.75

4183

29046

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3523

23313

1.71

144.11

1.9

1.7

0.95

1.17

mg/l

5.83

2688

17824

(3024561) Albumin [Mass/volume] in Serum or Plasma

5979

45390

1.61

141.23

4.6

4.7

36.04

35.56

g/l

10.34

5515

42170

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5913

44860

1.60

139.37

2.5

2.3

80.29

2106.11

nmol/l

0.50

5371

40429

(3037467) Urinalysis macro (dipstick) panel - Urine

8728

72802

1.66

138.31

5.1

4.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

8113

66644

1.62

134.78

3.6

3.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

8429

70043

1.62

132.02

5.4

4.4

1016.39

1770.47

e6/l

0.98

941

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2985

19402

1.71

127.79

3.0

2.44

2.45

mmol/l

5.01

2578

16996

(3018095) Leukocytes [#/volume] in Urine

4963

36898

1.57

122.20

4.3

3.6

57.51

104.01

e6/l

7.78

3501

25861

(3044889) 12 lead EKG panel

8678

73199

1.61

122.08

4.3

3.7

—

(3048689) Calprotectin [Mass/mass] in Stool

2167

13028

1.80

121.29

2.1

2.2

111.66

129.13

ug/g

1.55

1707

10200

(3015377) Calcium [Moles/volume] in Serum or Plasma

4857

36040

1.57

119.96

3.3

3.4

2.35

2.36

mmol/l

1.32

4271

31707

(36304419) Bacteria [Presence] in Urine

3945

28037

1.59

116.55

3.4

3.0

—

(3030467) Casts [#/volume] in Urine by Automated count

4022

28755

1.59

115.65

3.5

3.1

0.29

0.42

e6/l

5.12

3037

21795

(40758558) Short blood count panel - Blood

3806

26880

1.60

115.17

6.6

6.8

—

(3033658) Prothrombin time (PT) actual/Normal

3756

26493

1.60

114.03

4.2

3.8

91.81

91.33

0.56

3666

25794

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6794

54876

1.52

110.22

5.8

6.1

10.84

11.09

umol/l

1.03

6415

52080

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2933

19724

1.64

107.18

4.3

3.6

228.74

441.61

ng/l

2.38

2192

14946

(3019550) Sodium [Moles/volume] in Serum or Plasma

11662

107925

2.18

105.85

19.4

15.7

139.77

139.67

mmol/l

3.91

11467

105283

(3002582) Erythrocytes [#/volume] in Urine

4256

31319

1.54

105.34

3.6

3.2

34.36

90.02

e6/l

6.49

3243

23928

(3013826) Glucose [Moles/volume] in Serum or Plasma

7342

60712

1.51

103.25

5.2

4.5

6.46

6.68

mmol/l

18.92

6973

56708

(3023103) Potassium [Moles/volume] in Serum or Plasma

11669

108220

2.16

101.93

19.6

15.8

3.94

3.96

mmol/l

13.77

11456

105361

(3037522) Nuclear Ab [Titer] in Serum

2325

14903

1.69

101.68

1.4

1.3

487.33

536.06

titre

0.62

464

3276

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2650

17635

1.64

99.97

3.0

2.7

0.85

1.35

e6/l

2.27

1477

10063

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1306

7089

1.94

99.45

3.7

3.3

4.42

4.45

pmol/l

0.73

1168

6292

(3002385) Erythrocyte distribution width [Ratio]

10184

90897

1.65

98.13

20.4

16.5

14.97

15.01

0.22

10038

89331

(40768804) Tissue Pathology biopsy report

5666

44788

1.48

97.09

2.3

2.1

—

(3021589) Normoblasts [#/volume] in Blood

5837

46425

1.48

96.90

9.9

9.4

0.00

e9/l

0.67

4681

37944

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2836

19335

1.60

96.39

1.3

26.64

33.77

iu/ml

1.71

906

6241

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

274

701

3.97

94.17

1.5

1.3

2.06

1.40

u/ml

0.45

166

387

(3000494) Fungus identified in Specimen by Culture

1959

12269

1.71

92.50

1.6

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2433

16283

1.61

88.23

3.2

2.9

2.42

3.05

e6/l

2.70

1267

8776

(3023419) Bacteria identified in Sputum by Culture

415

1451

2.92

86.98

3.0

2.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11872

111813

2.20

83.73

12.2

10.4

25.22

25.46

u/l

0.71

11550

107890

(3021960) Folate [Moles/volume] in Serum or Plasma

3320

24094

1.51

83.30

1.6

1.5

21.79

20.61

nmol/l

2.77

2931

20554

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2646

18318

1.56

82.28

1.3

10.19

12.32

u/ml

0.49

958

7244

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11048

101848

1.72

80.93

5.1

4.5

5.82

5.90

mmol/l

10.21

10253

93075

(3000850) Epithelial cells [#/volume] in Urine

3048

21900

1.52

79.53

2.7

2.6

4.86

6.01

e6/l

6.13

2703

19560

(3011397) Hemoglobin [Presence] in Urine by Test strip

3350

24570

1.50

79.08

4.0

3.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1573

9658

1.72

78.85

2.3

2.2

358.13

374.21

nmol/l

2.68

1444

8871

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1734

10959

1.68

77.97

1.8

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1736

10981

1.67

77.79

1.8

1.7

—

(40761511) CBC panel - Blood by Automated count

11656

109390

1.95

77.65

15.4

13.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3815

28839

1.46

76.86

3.0

2.9

1042.77

1337.05

ng/l

5.04

3260

24729

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10515

96062

1.59

75.79

5.9

5.6

38.89

39.57

mmol/mol

14.35

9841

88860

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2357

16191

1.56

74.93

1.9

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1312

7782

1.77

74.06

2.6

2.8

10.07

10.48

g/l

2.58

1199

7131

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2410

16738

1.54

72.65

3.1

3.3

0.82

mmol/l

1.30

2248

15674

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1558

9747

1.68

72.42

2.6

2.4

56.91

42.74

u/l

0.27

1323

8318

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

632

2945

2.21

72.12

1.5

1.4

—

(36660697) Celiac disease serology panel - Serum

1384

8395

1.73

72.08

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3509

26359

1.46

72.04

2.3

2.77

2.95

mg/l

4.28

2994

22585

(3009261) Glucose [Presence] in Urine by Test strip

6308

52611

1.40

71.90

4.1

3.7

0.00

estimate

2.88

1110

9615

(3035350) Ketones [Presence] in Urine by Test strip

6244

52006

1.40

71.63

4.1

3.7

0.00

estimate

0.13

1187

10368

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4385

34361

1.43

71.50

3.1

3.2

30.70

33.96

u/l

3.12

4136

32566

(3021601) Nitrite [Presence] in Urine by Test strip

6252

52095

1.40

71.48

5.6

4.9

0.00

estimate

0.07

1137

9793

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7963

69362

1.41

68.82

3.3

3.0

46.26

46.21

u/l

0.02

7433

64604

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

588

2746

2.20

66.67

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

281

919

3.10

66.23

3.8

3.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

5745

47572

1.38

66.12

15.8

14.3

1.23

1.26

inr

0.71

1574

13866

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4209

33137

1.41

65.21

2.7

2.5

61.08

61.69

u/l

0.07

3883

30576

(3015736) pH of Urine

5142

41872

1.39

65.20

3.7

3.4

5.93

5.87

0.59

376

3216

(3010813) Leukocytes [#/volume] in Blood

12153

116601

2.46

64.49

25.9

20.6

6.58

6.68

e9/l

6.32

11910

113354

(3007461) Platelets [#/volume] in Blood

12148

116533

2.45

64.47

25.9

20.6

252.65

254.87

e9/l

3.44

11940

113622

(3035941) MCH [Entitic mass]

12150

116586

2.45

63.99

25.7

20.5

30.30

30.27

1.21

12045

115013

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

10715

99152

1.56

63.86

15.7

12.9

81.01

81.02

ml/min/173m2

0.01

9090

82021

(3024731) MCV [Entitic volume]

12150

116595

2.44

63.82

25.8

20.5

91.18

91.04

3.17

12044

115021

(3026361) Erythrocytes [#/volume] in Blood

12150

116604

2.44

63.64

25.9

20.6

4.46

e12/l

0.26

11904

113396

(3000963) Hemoglobin [Mass/volume] in Blood

12151

116632

2.44

63.37

26.0

20.7

134.14

134.26

g/l

0.43

12050

115064

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1208

7316

1.72

62.82

2.4

24.37

24.59

au/ml

0.02

583

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11269

105639

1.67

62.47

5.5

4.8

2.74

2.79

mmol/l

7.78

10517

97490

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1798

12076

1.57

61.88

2.6

7.00

8.09

umol/l

1.24

1543

10385

(3009542) Hematocrit [Volume Fraction] of Blood

12131

116439

2.36

61.84

26.1

20.6

40.05

40.08

0.11

11462

109185

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

295

1035

2.89

61.43

5.7

4.7

66.83

117.82

u/ml

0.91

317

(3015171) Extractable nuclear Ab [Units/volume] in Serum

816

4435

1.90

60.80

1.3

0.68

1.12

u/ml

0.71

406

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1109

6685

1.72

58.47

1.3

53.10

52.88

au/ml

0.01

377

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4759

38858

1.36

56.80

3.9

3.5

130.48

54.71

ng/l

0.33

3027

25835

(3026782) Osmolality of Urine

2760

20595

1.44

56.16

3.0

2.9

528.12

531.80

mosm/kgh2o

0.39

2337

17638

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2162

15405

1.49

55.93

2.1

29.82

29.76

0.17

2089

14950

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3564

27832

1.39

55.85

1.7

1.6

1.31

1.36

mmol/l

2.99

3076

23360

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

219

693

3.20

54.62

7.2

6.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

1784

12271

1.53

54.55

1.9

1.7

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

282

1035

2.76

54.01

1.4

6.06

6.84

g/l

3.24

203

719

(3024139) IgG subclass 3 [Mass/volume] in Serum

282

1035

2.76

54.01

1.4

0.39

0.41

g/l

0.29

204

718

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

619

3189

1.99

53.92

1.8

1.7

0.23

g/l

1.63

586

3008

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11051

103710

1.56

53.79

4.8

4.4

4.67

4.73

mmol/l

6.60

10351

96179

(3028026) IgM [Mass/volume] in Serum or Plasma

1012

6085

1.72

53.67

1.9

1.18

1.36

g/l

2.71

935

5529

(3028192) IgG subclass 2 [Mass/volume] in Serum

281

1035

2.75

53.45

1.4

2.78

2.91

g/l

0.70

203

718

(3023368) Bacteria identified in Blood by Culture

3466

27144

1.38

52.74

4.5

4.2

—

(3003338) MCHC [Mass/volume]

9702

88889

1.41

52.52

23.1

17.8

331.69

331.80

g/l

0.64

9641

88274

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10975

102989

1.53

51.79

4.8

4.3

1.51

1.50

mmol/l

1.74

10236

95067

(4062490) Immunoglobulin typing, IgG

278

1036

2.72

51.71

1.5

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1158

7296

1.65

51.38

1.3

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

625

3292

1.95

51.02

1.8

1.7

1.18

g/l

0.17

594

3110

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1240

7971

1.62

50.72

3.6

3.7

80.63

88.98

ng/l

2.44

1092

6866

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1193

7601

1.63

50.58

1.2

110.70

151.00

iu/ml

3.62

446

2932

(3003327) Ova and parasites identified in Stool by Light microscopy

654

3542

1.89

49.07

1.8

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3476

27491

1.37

49.00

2.6

2608.10

4277.45

umol/l

2.40

3025

24023

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

757

4308

1.81

48.47

1.1

32.49

1.75

u/ml

0.46

(3022145) Colonoscopy Study observation

1706

11931

1.50

47.66

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

380

1711

2.26

47.04

1.1

4.09

4.85

u/ml

0.44

203

828

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

408

1893

2.19

46.94

1.2

1.1

0.92

2.22

u/ml

3.55

214

897

(3010726) Horse dander IgE Ab [Units/volume] in Serum

353

1550

2.31

46.37

1.2

1.1

1.23

1.37

u/ml

0.18

191

733

(3024980) IgG subclass 4 [Mass/volume] in Serum

367

1652

2.26

45.46

1.5

0.60

0.74

g/l

2.33

280

1239

(3026008) Bacteria identified in Urine by Culture

4057

33158

1.33

45.12

3.4

3.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

359

1618

2.25

44.34

1.2

1.1

14.56

10.27

au/ml

0.43

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

429

2092

2.09

43.42

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

429

2092

2.09

43.42

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

544

2890

1.92

43.23

2.7

2.2

0.01

0.03

g/l

1.04

489

2629

(3008401) Mugwort IgE Ab [Units/volume] in Serum

359

1642

2.22

42.79

1.1

0.68

1.02

u/ml

0.90

162

657

(1002224) Polysomnography panel

704

4079

1.77

42.32

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

875

5394

1.67

41.98

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

509

2688

1.93

41.17

2.7

2.3

0.00

g/l

0.17

455

2434

(3022948) Iron [Moles/volume] in Serum or Plasma

2190

16496

1.40

40.42

2.5

13.56

13.02

umol/l

3.03

2054

15345

(3042936) Bacteria identified in Isolate by Culture

1950

14423

1.42

39.94

2.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10575

99471

1.41

39.94

4.2

3.9

1.25

1.28

mmol/l

3.96

9766

91078

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

499

2646

1.92

39.87

2.7

2.3

0.00

g/l

-0.00

454

2423

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

548

2996

1.87

39.86

2.6

2.2

38.21

37.73

g/l

1.25

482

2598

(3014111) Lactate [Moles/volume] in Serum or Plasma

1256

8568

1.52

39.05

8.0

6.7

1.30

1.32

mmol/l

0.30

1215

8358

(3014765) Yersinia sp identified in Stool by Organism specific culture

555

3069

1.85

38.93

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

550

3040

1.85

38.64

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

556

3086

1.84

38.54

1.4

279.84

276.11

ug/g

0.16

327

1767

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5733

49820

1.28

38.12

2.7

2.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

553

3077

1.83

38.02

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

328

1520

2.19

37.88

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

582

3294

1.80

37.84

2.8

2.4

0.64

0.87

g/l

0.96

500

2816

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

885

5627

1.62

37.45

2.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

322

1493

2.19

37.14

1.3

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2491

19395

1.36

37.02

1.8

1.7

1146.82

1173.62

nmol/l

0.76

1861

14693

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1115

7502

1.53

36.88

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1235

8500

1.50

36.68

3.0

2.8

154.16

188.24

ng/l

2.90

1124

7772

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

624

3649

1.75

36.26

2.6

2.3

2.91

2.94

g/l

0.26

558

3263

(3014133) Dog dander IgE Ab [Units/volume] in Serum

296

1344

2.23

35.96

1.1

4.62

3.36

u/ml

0.24

144

586

(3023430) Cat dander IgE Ab [Units/volume] in Serum

281

1250

2.28

35.86

1.1

3.23

3.66

u/ml

0.20

123

467

(3009445) Proteinase 3 Ab [Units/volume] in Serum

718

4411

1.67

34.78

1.7

1.6

6.66

14.97

u/ml

1.99

126

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

169

600

2.84

34.59

1.1

7.93

8.16

nmol/l

0.02

121

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

613

3618

1.73

34.46

2.7

2.3

9.64

10.16

g/l

2.42

546

3198

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

650

3901

1.70

34.38

2.6

2.3

7.07

7.44

g/l

7.88

584

3510

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

649

3897

1.70

34.26

2.6

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

648

3894

1.70

34.11

2.6

2.3

3.62

3.67

g/l

0.41

581

3505

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1989

15161

1.37

33.46

2.5

2.36

2.35

g/l

0.49

1839

14013

(3020961) Endomysium IgA Ab [Titer] in Serum

793

5046

1.61

33.37

1.1

239.00

196.80

titre

0.09

120

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

436

2350

1.89

33.15

1.2

1.3

43.52

44.37

u/ml

0.03

251

(3025941) Bacteria identified in Stool by Culture

913

6022

1.56

32.92

1.3

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1202

8422

1.47

32.49

2.5

2.6

66.33

66.44

g/l

0.20

1094

7625

(3014576) Chloride [Moles/volume] in Serum or Plasma

1672

12513

1.39

31.30

7.8

6.8

104.67

104.39

mmol/l

1.80

1672

12505

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

704

4424

1.63

31.14

2.0

39.00

39.29

u/l

0.14

623

3912

(44813793) Dust mix specific IgE antibody measurement

184

726

2.56

30.68

1.1

—

(3000991) Gas panel - Venous blood

1171

8251

1.46

30.67

9.3

7.9

—

(3052851) Hemolysis interference index of Serum or Plasma

536

3154

1.73

30.45

3.1

3.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1740

13163

1.37

30.42

5.4

5.6

1.02

1.04

mmol/l

2.89

1607

12264

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

536

3163

1.73

30.14

1.3

4.89

41.28

u/ml

10.63

201

(3036489) Thrombin time

610

3743

1.66

29.64

2.0

2.1

21.47

21.46

0.01

539

3241

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

176

693

2.56

29.49

1.0

1.1

7.85

8.92

iu/ml

0.22

171

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

243

1105

2.22

29.48

1.1

1.0

0.15

0.40

u/ml

0.94

287

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

494

2868

1.75

29.43

2.4

2.5

180.35

190.65

1.94

464

2721

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1192

8497

1.45

29.31

2.4

2.3

5.86

7.04

ug/l

1.23

1017

7368

(46235355) HIV 1 and 2 tests - Meaningful Use set

2177

17135

1.33

29.19

1.9

1.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1842

14148

1.35

29.12

2.6

2.5

22.83

22.44

0.59

1605

12038

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

642

4013

1.63

29.00

1.7

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

872

5859

1.52

28.81

1.8

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

3955

33657

1.26

28.69

2.5

2.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

719

4636

1.58

28.55

4.5

4.3

24.34

24.20

mmol/l

0.70

698

4544

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

554

3375

1.67

27.68

2.9

2.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1515

11382

1.38

27.44

8.0

6.9

12.17

12.50

kpa

1.73

1452

10857

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1515

11387

1.38

27.36

8.0

6.9

5.02

5.08

kpa

1.91

1454

10867

(3004588) Protein electrophoresis panel - Serum or Plasma

993

6935

1.47

27.12

2.6

2.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1300

9564

1.40

26.67

1.5

1.4

—

(3003396) Base excess in Arterial blood by calculation

1503

11354

1.37

26.23

8.0

6.9

1.05

1.10

mmol/l

0.21

1249

9038

(3024891) Influenza virus A+B Ag [Presence] in Specimen

444

2586

1.74

26.17

1.2

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3056

25471

1.26

25.94

2.5

2.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

769

5144

1.53

25.90

10.6

8.8

24.38

24.34

mmol/l

0.14

744

4997

(3017446) Testosterone [Moles/volume] in Serum or Plasma

796

5365

1.52

25.87

2.3

2.1

12.16

11.80

nmol/l

0.60

708

4710

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1820

14205

1.33

25.54

3.3

3.1

0.70

0.77

ug/l

2.29

1303

9778

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

555

3478

1.62

24.81

1.6

120.95

283.53

titre

2.47

160

(3027945) Reticulocytes/100 erythrocytes in Blood

1483

11289

1.36

24.54

2.4

2.5

1.75

1.78

0.48

1318

9977

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

421

2500

1.71

23.17

1.3

475.31

533.17

mg/l

1.89

408

2371

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

498

3096

1.63

23.00

2.3

2.2

94.10

92.63

0.86

478

2974

(3044290) Cell count panel - Cerebral spinal fluid

358

2036

1.78

22.95

1.2

1.4

—

(3002032) Base excess in Venous blood by calculation

1205

8986

1.38

22.63

4.0

3.9

2.05

1.96

mmol/l

0.43

1032

7617

(3008898) HLA-B27 [Presence]

562

3613

1.58

22.59

1.1

—

(3016502) Oxygen saturation in Arterial blood

1337

10140

1.36

22.56

8.5

7.3

95.97

95.69

0.98

1294

9745

(3012544) pH of Venous blood

1245

9340

1.37

22.52

4.0

3.9

7.37

7.38

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

150

625

2.42

22.40

1.3

1.5

4.91

6.18

u/l

2.44

124

533

(3026389) Candida sp identified in Specimen by Organism specific culture

303

1652

1.85

22.32

1.5

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

877

6203

1.45

22.31

10.1

8.7

94.22

93.97

0.68

877

6179

(4094501) Cardiovascular stress test using bicycle ergometer

446

2726

1.66

22.03

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

455

2798

1.65

21.95

1.9

2.1

10.85

11.17

mg/l

0.40

415

2594

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

469

2922

1.63

21.48

1.1

6.66

6.53

u/ml

0.01

370

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1200

9018

1.37

21.43

4.1

3.9

5.86

5.84

kpa

0.30

1158

8754

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

450

2782

1.64

21.26

1.9

4.14

7.63

iu/l

0.60

181

1030

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

161

3.87

21.14

1.1

1.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

467

2919

1.62

21.12

1.3

10.50

6.63

u/ml

0.38

473

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

250

1308

1.93

20.93

1.6

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1238

9392

1.35

20.77

8.9

7.6

122.03

120.66

g/l

1.69

1212

9124

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

466

2929

1.61

20.60

2.9

2.6

3.62

3.61

g/l

0.07

449

2769

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

450

2806

1.63

20.55

1.5

1.4

13.14

13.76

iu/ml

0.05

(40768443) Skin Pathology biopsy report

696

4786

1.48

20.48

1.2

—

(3002256) Pathology report gross observation

1786

14293

1.29

20.47

1.3

—

(3049717) Cytology report of Urine Cyto stain

556

3647

1.55

20.47

2.5

2.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2923

24782

1.23

20.44

5.6

5.1

3.57

3.35

ug/l

0.07

2649

22117

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

458

2879

1.61

20.25

1.3

8.36

6.43

u/ml

0.14

301

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

762

5354

1.45

20.06

10.8

9.2

—

(3000060) B lymphocytes [#/volume] in Blood

267

3.08

19.77

1.8

2.1

560.59

508.41

e6/l

0.04

138

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2382

19814

1.25

19.74

4.8

4.4

22.84

21.94

1.96

1144

10027

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

466

2960

1.60

19.73

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

363

2187

1.68

18.99

1.2

1.4

24.79

34.02

e6/l

0.23

271

1688

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

520

3420

1.54

18.93

1.9

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

159

733

2.18

18.83

1.9

2.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1448

11389

1.31

18.82

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

143

632

2.28

18.76

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1463

11531

1.30

18.72

4.0

4.2

232.23

244.19

u/l

4.16

1389

10871

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

362

2188

1.67

18.71

1.3

1.4

482.71

3137.16

e6/l

0.93

286

1786

(3019420) Tryptase [Mass/volume] in Serum or Plasma

128

544

2.37

18.38

1.5

7.51

8.26

ug/l

0.20

116

484

(3023323) Follitropin [Units/volume] in Serum or Plasma

785

5644

1.42

18.21

1.4

1.3

30.38

31.51

iu/l

0.42

677

4905

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1126

8587

1.34

18.17

2.7

2.6

68.47

66.38

ml/min/173m2

1.14

514

3405

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

359

2191

1.66

17.90

1.2

1.3

3.65

3.74

mmol/l

1.28

333

2059

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

431

2752

1.59

17.88

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

144

654

2.22

17.72

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

202

1043

1.95

17.66

1.1

—

3.45

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

197

1017

1.95

17.24

1.1

—

71.36

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

818

5998

1.39

16.91

7.4

7.0

25.00

24.82

mmol/l

0.79

809

5955

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

378

2372

1.61

16.88

1.2

7.61

4.35

u/ml

0.33

176

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

349

2148

1.64

16.86

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1297

10207

1.30

16.69

2.2

2.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

738

5335

1.41

16.59

1.3

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

149

709

2.11

16.34

1.9

2.6

498.11

515.77

e6/l

0.20

122

589

(40761535) Cells panel - Urine sediment

1108

8557

1.32

16.34

3.9

3.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

215

1168

1.86

16.15

1.7

1.5

53.57

27.74

iu/ml

0.87

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

236

1333

1.79

15.63

1.8

175.94

191.13

pmol/l

1.43

215

1248

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

143

682

2.11

15.62

1.9

2.6

0.25

0.23

e9/l

0.73

121

587

(3011412) CD3 cells [#/volume] in Blood

191

1011

1.90

15.57

1.9

2.4

1.21

1.20

e9/l

0.06

168

903

(3039162) Centromere protein B Ab [Units/volume] in Serum

246

1410

1.76

15.50

1.2

1.3

35.29

58.34

u/ml

0.93

104

(3051611) Lipemic interference index of Serum or Plasma

203

1098

1.86

15.48

3.2

3.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

275

1630

1.70

15.37

1.3

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1162

9114

1.30

15.29

2.0

1.9

—

(3023410) Appearance of Cerebral spinal fluid

184

968

1.91

15.29

1.3

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

161

811

2.00

15.18

1.2

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

374

2.50

15.15

1.2

0.31

g/l

0.25

294

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

161

812

2.00

15.13

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

161

812

2.00

15.13

1.2

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

485

3301

1.49

15.06

1.7

1.6

300.34

306.51

mu/l

0.16

444

2966

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

346

2.55

15.03

1.2

108.34

111.60

0.50

302

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2301

19561

1.22

15.01

1.5

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

176

919

1.93

14.96

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

161

817

1.98

14.88

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

161

817

1.98

14.88

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

161

819

1.98

14.78

1.2

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

154

778

1.99

14.43

1.2

1.1

30.85

42.24

mg/l

5.01

133

646

(3016018) Differential panel - Cerebral spinal fluid

195

1066

1.84

14.41

1.2

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

382

2500

1.54

14.30

1.3

12.93

12.27

u/l

0.35

301

2035

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

790

5923

1.36

14.21

1.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

103

449

2.30

14.08

1.8

2.3

834.05

190.45

ug/l

0.36

420

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

194

1067

1.83

14.07

1.2

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

149

751

2.00

14.06

1.1

229.60

259.93

mg/l

1.69

136

653

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

144

717

2.02

14.06

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

120

558

2.16

14.03

1.8

2.2

99.85

98.56

0.16

109

513

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

795

5980

1.35

14.00

2.0

1.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.15

13.63

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

953

7398

1.31

13.50

3.5

3.3

4.44

4.58

kpa

1.23

913

7157

(3038177) Helicobacter pylori Ab [Presence] in Serum

287

1781

1.63

13.50

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

256

1544

1.67

13.47

1.2

3.71

3.32

u/ml

0.13

510

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

189

1049

1.81

13.34

1.3

1.2

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.35

13.29

1.3

1.6

3.59

2.60

mg/l

0.33

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.35

13.29

1.3

1.6

2.47

2.22

mg/l

0.07

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.35

13.29

1.3

1.6

1.59

2.09

mg/l

0.23

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.35

13.29

1.3

1.6

0.54

1.46

mg/l

0.75

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.35

13.29

1.3

1.6

2.37

3.57

mg/l

0.53

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.35

13.29

1.3

1.6

1.94

2.80

mg/l

0.41

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.35

13.29

1.3

1.6

1.63

2.08

mg/l

0.26

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.35

13.29

1.3

1.6

4.06

4.30

mg/l

0.07

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.35

13.29

1.3

1.6

1.79

1.11

mg/l

0.31

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.57

13.26

1.1

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

281

1743

1.63

13.25

1.4

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4425

40125

1.16

13.21

4.4

3.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

352

2306

1.54

13.15

1.4

1.7

—

(3024928) Oxygen saturation in Venous blood

315

2021

1.57

12.91

4.1

3.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

480

3363

1.44

12.89

2.1

2.3

361.88

590.90

ug/l

0.99

451

3154

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

249

1512

1.66

12.79

1.2

3.33

4.05

u/ml

0.78

111

648

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.19

12.67

1.3

1.6

0.86

2.50

mg/l

1.40

(3019150) Specific gravity of Urine by Refractometry

2600

22700

1.18

12.38

4.6

4.1

1.02

kg/l

0.26

349

3445

(3045414) Leukocytes [Presence] in Urine

655

4888

1.36

12.16

2.1

1.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1744

14711

1.22

12.08

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

935

7354

1.29

12.00

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

181

2.94

11.93

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

626

4657

1.36

11.86

1.9

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2580

22581

1.18

11.86

1.7

32586822.13

34116825.57

pmol/l

0.04

2142

18730

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

355

2384

1.50

11.85

1.4

1.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

309

2017

1.55

11.78

2.0

1.9

4.86

5.11

mmol/24h

0.70

271

1778

(3029937) Albumin [Presence] in Urine by Test strip

3155

28084

1.17

11.72

4.7

4.1

0.00

estimate

3.03

1139

9502

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

143

3.15

11.46

1.2

1.0

0.25

6.24

u/ml

0.86

101

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

276

1771

1.57

11.36

1.3

1.4

117.91

114.05

u/ml

0.15

388

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

308

2028

1.53

11.30

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1082

8738

1.26

11.21

6.5

7.2

9.15

9.71

mmol/l

1.91

1027

8332

(3023520) Reticulocytes [#/volume] in Blood

1053

8478

1.26

11.20

2.4

2.6

70.18

70.03

e9/l

0.05

756

6402

(3048929) Epstein Barr virus Ab [Presence] in Serum

417

2924

1.44

11.19

1.2

—

(3019060) Gas panel - Arterial blood

840

6577

1.30

11.17

4.6

4.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

289

2.43

10.91

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

254

2.53

10.85

1.2

1.3

151.80

124.79

nmol/l

0.53

185

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

150

829

1.82

10.83

1.3

1.2

171.03

164.66

titre

0.04

146

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

347

2.28

10.72

1.1

113.87

109.62

0.48

312

(3020874) Milk IgE Ab [Units/volume] in Serum

118

606

1.96

10.68

1.1

5.85

1.53

u/ml

0.39

188

(3017732) Neutrophils [#/volume] in Blood

940

7512

1.27

10.63

2.6

2.8

5.07

4.83

e9/l

0.17

774

6059

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

266

1722

1.56

10.57

1.4

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

404

2851

1.43

10.50

2.6

2.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

212

1306

1.63

10.38

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.69

10.38

2.1

1.7

45.94

44.14

umol/l

0.13

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

252

1621

1.57

10.31

1.3

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

252

1621

1.57

10.31

1.3

1.6

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

148

829

1.79

10.25

1.3

1.2

74.00

170.00

titre

—

(3035637) Corticotropin [Mass/volume] in Plasma

210

1298

1.63

10.16

1.6

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

115

597

1.93

10.11

1.7

1.6

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

102

510

2.01

9.99

1.1

6.90

6.87

u/ml

0.00

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

293

1964

1.50

9.94

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

181

1084

1.68

9.91

1.4

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

181

1084

1.68

9.91

1.4

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

3541

32098

1.14

9.90

3.1

3.2

7.30

7.26

mmol/l

0.20

2989

27011

(3044941) Cell count panel - Synovial fluid

244

1575

1.56

9.85

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

238

1529

1.57

9.81

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

157

2.87

9.81

1.3

39.15

41.49

mg/l

0.13

135

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

342

2.23

9.78

1.1

93.19

88.61

0.61

147

(3000475) Leukocytes [#/volume] in Synovial fluid

358

2506

1.44

9.75

1.5

1.6

14040.63

13736.18

e6/l

0.03

259

1801

(3007566) Smooth muscle Ab [Titer] in Serum

408

2925

1.41

9.73

1.2

117.83

129.20

titre

0.12

261

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

448

2.06

9.70

1.2

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

337

2.23

9.69

1.0

1.2

93.10

90.18

0.21

152

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

206

1292

1.60

9.43

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

434

2.06

9.36

1.3

1.7

2.08

1.98

umol/l

0.58

403

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

135

757

1.79

9.36

1.5

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

229

1476

1.56

9.33

1.1

2.15

3.45

u/ml

1.88

697

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

236

1532

1.55

9.32

1.3

0.62

1.63

nmol/l

0.70

223

1479

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

288

1951

1.49

9.31

1.2

—

(3021788) Differential panel - Synovial fluid

276

1856

1.50

9.25

1.4

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

342

2399

1.44

9.24

1.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

236

1538

1.54

9.17

1.3

0.16

0.24

nmol/l

1.03

106

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

594

4563

1.32

9.13

1.8

1.7

1.51

1.55

g/l

0.63

513

3894

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

216

1384

1.57

9.05

1.4

1.5

—

(3034770) Mitochondria Ab [Titer] in Serum

404

2930

1.39

9.04

1.2

773.00

955.60

titre

—

109

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

232

1512

1.54

9.02

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

176

1075

1.65

8.98

1.1

92.21

94.84

0.60

163

1011

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

104

545

1.92

8.95

1.0

1.1

1.01

1.09

u/l

1.15

247

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

224

1455

1.55

8.85

1.1

120.35

118.66

0.34

202

1305

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

271

1834

1.49

8.83

1.2

289.46

276.78

u/ml

0.26

173

1158

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1173

9804

1.22

8.82

2.3

2.2

0.22

0.21

g/l

3.95

1091

9147

(3013512) EKG study

3334

30289

1.14

8.82

4.1

3.8

—

(21491868) Cryoglobulin [Mass/volume] in Serum

364

2.12

8.81

1.2

1.1

0.78

0.13

g/l

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1369

11619

1.20

8.76

1.6

1.7

1.43

0.06

1181

10162

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

444

3289

1.36

8.73

2.8

3.2

0.35

u/ml

0.04

233

1881

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

125

703

1.79

8.62

1.4

12.20

12.48

umol/l

0.18

118

665

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1388

11814

1.20

8.61

1.7

—

(3042631) Mycobacterium sp identified in Specimen

215

1399

1.55

8.45

3.0

2.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

334

2373

1.42

8.45

2.1

2.2

129.32

128.68

g/l

0.18

209

1707

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

214

1394

1.54

8.37

1.3

—

(3011985) Renin [Units/volume] in Plasma

219

1439

1.53

8.24

1.5

42.44

58.26

mu/l

1.03

188

1285

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

206

1337

1.55

8.20

1.4

1.5

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

330

2.13

8.11

2.0

2.3

1.29

1.04

ug/l

0.34

313

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

522

1.88

8.07

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

290

2031

1.44

7.96

4.8

5.4

1091.53

1975.38

iu/ml

0.39

291

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

433

3244

1.35

7.95

1.5

1.6

0.28

9.50

iu/ml

1.09

104

707

(3014599) Egg white IgE Ab [Units/volume] in Serum

108

598

1.81

7.88

1.1

1.0

2.04

0.77

u/ml

0.62

135

(3015076) Soybean IgE Ab [Units/volume] in Serum

535

1.86

7.82

1.1

1.0

0.40

0.95

u/ml

0.41

124

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

166

1042

1.60

7.66

2.1

2.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

292

2063

1.43

7.66

2.4

2.9

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

145

2.69

7.64

1.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

211

1400

1.52

7.63

1.1

1.48

1.52

g/l

0.74

193

1265

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

140

846

1.66

7.53

1.3

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

390

2903

1.35

7.50

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

390

1.98

7.39

1.5

1.4

14.89

15.16

pmol/l

0.16

320

(3019832) Treponema pallidum Ab [Presence] in Serum

996

8336

1.21

7.39

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

168

1069

1.58

7.34

1.3

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

258

1797

1.44

7.33

1.4

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

157

985

1.60

7.29

1.3

1.8

—

(3051651) Icteric interference index of Serum or Plasma

109

621

1.76

7.27

3.7

3.3

—

(3012516) Albumin [Mass/volume] in Urine

3284

30124

1.12

7.15

3.2

498.96

416.74

mg/l

0.38

2019

18618

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

139

2.67

7.12

1.3

1.4

0.25

0.29

nmol/l

0.16

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

163

2.52

7.06

1.8

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

519

1.82

6.98

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

421

3216

1.32

6.83

3.6

3.3

54.30

71.78

mg/l

0.41

351

2604

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

411

3132

1.32

6.78

3.5

3.2

4.32

2.78

ratio

0.22

250

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

484

3772

1.29

6.77

3.3

3.4

345.33

2032.60

u/ml

1.47

409

3208

(3008152) Bicarbonate [Moles/volume] in Arterial blood

762

6274

1.23

6.67

6.7

6.9

24.79

24.61

mmol/l

0.79

736

5958

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

144

2.57

6.67

1.2

1.5

203339.32

257731.42

nmol/l

0.08

123

(3041096) Erythrocytes [Presence] in Urine by Automated

3065

28101

1.12

6.65

3.6

3.3

—

(3037756) Immunofixation for Serum or Plasma

290

2101

1.39

6.65

1.6

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

419

3214

1.31

6.61

3.6

3.3

38.25

46.44

mg/l

0.60

348

2606

(3002179) Metamyelocytes/100 leukocytes in Blood

972

8208

1.20

6.58

4.0

0.68

0.72

0.17

284

2651

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

128

2.66

6.55

1.1

1.0

0.00

0.37

u/ml

1.00

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

163

1064

1.54

6.43

1.6

1040.00

1280.00

titre

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

3.13

6.42

1.0

0.05

4.71

u/ml

0.52

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

276

2000

1.39

6.34

1.3

1.2

55.56

173.18

titre

—

(21494755) Public health laboratory ask at order entry panel

802

9568

0.83

6.20

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

277

2.06

6.20

1.1

0.69

5.11

u/ml

0.75

144

(3017181) Myelocytes/100 leukocytes in Blood

1053

9005

1.18

6.19

4.1

0.86

0.97

0.77

331

3051

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

115

2.70

6.16

1.4

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

138

877

1.58

6.14

1.3

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

138

877

1.58

6.14

1.3

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

138

877

1.58

6.14

1.3

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1215

10522

1.17

6.13

3.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

364

2769

1.32

6.12

1.3

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

196

1345

1.46

6.10

1.4

1.3

311.11

337.14

pmol/l

0.34

174

1160

(3025159) Blasts/100 leukocytes in Blood

958

8144

1.19

6.03

4.2

0.08

0.37

2.30

239

2225

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

552

1.73

6.00

2.1

2.8

43.73

39.83

1.32

321

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

457

1.80

5.97

1.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

724

6003

1.22

5.95

3.7

3.5

1.76

1.79

mmol/l

0.06

559

4445

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

548

1.72

5.88

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

123

772

1.60

5.80

1.0

1.1

289.01

294.08

mg/l

0.34

109

694

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

551

1.71

5.77

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

225

2.14

5.76

1.1

99.50

79.89

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

3.07

5.75

1.0

0.11

0.60

u/ml

0.64

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

100

599

1.67

5.68

1.3

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

302

2267

1.34

5.60

3.8

3.0

8.32

8.21

kpa

0.61

295

2217

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

385

2991

1.30

5.59

1.6

1.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

1000

8591

1.18

5.58

4.2

0.11

0.12

0.06

280

2639

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1468

12988

1.15

5.56

8.1

6.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

163

1100

1.49

5.56

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

456

1.76

5.44

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

456

1.76

5.44

1.4

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3401

31640

1.10

5.43

3.7

3.8

6.63

9.09

mg/mmol

3.63

2045

19436

(3020891) Body temperature

495

3985

1.25

5.39

4.1

4.8

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

707

5910

1.21

5.37

3.8

3.4

128.49

128.51

g/l

0.01

684

5772

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

488

1.73

5.36

3.8

3.9

—

(3009343) pH of Capillary blood

741

6224

1.20

5.35

3.8

3.5

7.43

7.42

1.51

115

834

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

749

6306

1.20

5.28

3.8

3.5

5.10

5.15

kpa

0.99

716

5974

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

218

1571

1.39

5.25

2.3

2.7

259.70

2143.58

u/ml

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

188

2.18

5.23

1.1

1.0

6.57

7.20

mg/g

0.29

177

(3005011) Chlamydia sp Ab [Titer] in Serum

150

2.34

5.22

1.8

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

688

5754

1.21

5.21

1.9

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.68

5.15

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

300

2280

1.32

5.15

1.5

1.6

—

(3022621) pH of Urine by Test strip

824

7016

1.19

5.13

3.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

122

789

1.55

5.11

1.2

1.3

2.01

2.06

mmol/l

0.15

116

733

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

406

1.78

5.11

1.1

139.48

522.38

ng/l

0.98

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

503

1.69

5.09

1.2

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1016

8813

1.17

5.05

4.2

3.7

1.22

1.23

mmol/l

2.73

878

7666

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

10.01

5.02

1.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.81

4.96

1.0

0.02

0.25

u/ml

0.53

(3033923) Metanephrine [Moles/time] in 24 hour Urine

219

2.06

4.95

1.0

1.1

1.17

0.66

umol/24h

0.71

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

139

934

1.49

4.90

1.3

1.5

—

(3011288) Drugs identified in Urine by Screen method

277

2101

1.33

4.85

1.8

2.8

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

188

2.13

4.82

1.1

1.0

0.36

2.34

u/ml

0.74

152

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

506

1.66

4.74

1.6

1.4

3.89

4.24

umol/l

0.44

473

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

213

1562

1.37

4.67

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

534

1.63

4.58

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

3.15

4.47

1.0

0.54

2.36

u/ml

0.48

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

2.69

4.40

1.0

3.46

0.86

u/ml

0.38

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

146

1014

1.45

4.40

1.2

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

320

2520

1.28

4.28

3.0

24.96

24.80

mmol/l

0.34

310

2470

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

239

1810

1.33

4.28

1.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.84

4.21

1.2

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

372

1.72

4.16

1.5

1.4

78.40

195.82

nmol/24h

1.45

372

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

457

3761

1.22

4.15

1.6

1.7

3.35

3.89

mg/l

0.77

337

2793

(3047181) Lactate [Moles/volume] in Blood

399

3237

1.24

4.15

6.0

5.6

1.27

1.30

mmol/l

0.24

362

2851

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

471

1.64

4.15

1.3

152.23

178.37

pmol/l

0.60

471

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

110

2.37

4.05

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

187

1379

1.36

4.02

1.4

1.3

—

(3021901) Oxygen saturation in Capillary blood

239

1828

1.31

4.02

2.6

2.8

—

(3008295) Osmolality of Serum or Plasma

145

1025

1.42

4.01

1.4

280.14

278.05

mosm/kgh2o

0.53

103

803

(3023511) Choriogonadotropin [Units/volume] in Urine

238

1821

1.31

3.99

1.2

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

136

951

1.43

3.99

2.4

3.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

169

1229

1.38

3.97

1.2

59.71

61.81

u/l

0.17

151

1094

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

290

1.80

3.92

1.1

1.0

6.48

11.59

u/ml

1.27

166

(3011841) English Walnut IgE Ab [Units/volume] in Serum

2.56

3.87

1.0

0.13

1.83

u/ml

0.76

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

490

1.60

3.81

1.7

1.6

1.77

4.41

nmol/l

1.87

408

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

101

2.38

3.80

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

398

1.66

3.79

1.3

3.0

—

(40767503) Oxygen content in Capillary blood by calculation

277

2179

1.28

3.79

2.5

16.33

16.22

0.16

145

1150

(3025130) Human papilloma virus identified in Specimen

214

1627

1.32

3.78

1.6

1.7

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.73

3.74

1.2

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

180

1336

1.35

3.74

1.9

2.1

22.17

26.30

mg/l

0.44

347

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

251

1954

1.29

3.73

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

620

1.52

3.72

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

184

1373

1.35

3.70

1.6

2.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

109

2.30

3.67

1.0

1.2

—

(3019225) pH of Specimen

1183

10609

1.13

3.67

4.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

379

1.67

3.66

2.4

2.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.86

3.62

1.2

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

425

3527

1.21

3.60

2.1

3497.22

4754.70

u/l

0.40

147

1355

(3030981) Hyaline casts [#/volume] in Urine by Automated count

626

5380

1.17

3.58

3.0

2.7

0.25

0.28

e6/l

0.37

597

5231

(3027315) Oxygen [Partial pressure] in Blood

288

2296

1.26

3.55

3.5

4.0

8.76

8.59

kpa

0.60

279

2253

(3017704) Immunofixation for Urine

531

1.55

3.55

1.3

1.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

103

701

1.47

3.53

1.3

1.2

89.16

84.15

u/l

0.23

605

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

218

1680

1.30

3.52

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

215

1654

1.31

3.52

1.4

0.40

nmol/l

0.03

159

1249

(3008536) Aspergillus sp Ab [Presence] in Serum

199

1.91

3.51

1.3

2.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.33

3.49

1.0

1.2

1.60

1.71

umol/24h

0.29

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

280

1.75

3.45

1.8

1.5

0.38

0.37

ug/l

0.05

180

(3039000) Anion gap in Blood

282

2254

1.26

3.42

7.2

6.5

11.32

11.20

mmol/l

0.23

260

2012

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.76

3.41

1.2

1.1

—

(3018572) Chloride [Moles/volume] in Blood

282

2255

1.26

3.41

7.2

6.5

104.62

105.15

mmol/l

0.97

260

2013

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

100

683

1.47

3.38

1.3

1.2

26.80

23.14

u/l

0.33

572

(3016244) Insulin [Units/volume] in Serum or Plasma

610

1.50

3.38

3.2

3.4

19.78

27.98

mu/l

1.99

580

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

295

2375

1.25

3.36

1.3

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

652

1.48

3.34

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

329

1.67

3.30

2.4

1.9

9.04

9.39

mg/l

0.17

270

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

152

1127

1.35

3.24

1.9

1.7

—

(3050794) Legionella sp Ab [Presence] in Serum

2.34

3.23

1.2

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

657

1.46

3.23

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

325

1.66

3.18

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

651

1.46

3.18

1.0

302.59

340.57

ng/l

0.77

445

(3012501) Base excess in Blood by calculation

282

2278

1.24

3.15

3.5

4.0

2.33

2.54

mmol/l

0.79

196

1549

(3013290) Carbon dioxide [Partial pressure] in Blood

282

2280

1.24

3.13

3.5

4.0

5.00

4.99

kpa

0.09

273

2238

(3003740) Influenza virus B Ag [Presence] in Specimen

197

1525

1.30

3.12

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

436

1.56

3.12

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

2.54

3.12

1.1

1.0

0.21

0.25

u/ml

0.09

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

397

1.59

3.11

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

655

1.45

3.10

1.0

802.40

712.41

ng/l

1.38

433

(3001964) Herpes simplex virus Ag [Presence] in Specimen

305

1.67

3.09

1.3

1.5

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

223

1.80

3.09

1.1

66.47

54.24

u/ml

0.48

215

(1616796) Gas panel - Central venous blood

281

2276

1.24

3.07

3.3

3.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

550

1.49

3.07

1.6

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

246

1.75

3.05

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

112

2.15

3.05

1.8

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

299

1.67

3.04

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

658

1.45

3.03

1.0

59.87

43.80

ng/l

0.43

441

(3028271) Lactate [Moles/volume] in Capillary blood

206

1613

1.28

3.01

1.9

1.8

1.55

1.69

mmol/l

1.79

200

1583

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

240

1.75

3.00

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

409

1.57

2.99

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

370

1.60

2.98

1.0

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

320

2640

1.22

2.95

3.5

3.3

1.46

1.53

mg/l

0.98

291

2427

(3022806) Fractional oxyhemoglobin in Capillary blood

169

1293

1.31

2.95

1.8

89.83

89.71

0.10

164

1278

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

103

730

1.41

2.92

1.2

1.3

—

(40761536) Microorganisms panel - Urine sediment

999

9003

1.12

2.90

4.3

3.9

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

6.67

2.86

1.0

—

(3022313) Gas panel - Capillary blood

519

4482

1.16

2.86

4.1

3.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

414

1.55

2.85

1.3

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

208

1643

1.27

2.85

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

367

1.58

2.84

1.3

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

101

718

1.41

2.82

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

179

1392

1.29

2.79

1.2

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

546

1.47

2.78

1.6

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

194

1526

1.28

2.76

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

240

1.71

2.72

1.2

283.96

327.12

pmol/l

0.45

175

(3035320) C reactive protein [Mass/volume] in Body fluid

107

774

1.39

2.72

3.0

2.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

151

1153

1.31

2.70

1.5

1.4

3.08

3.99

ug/l

0.48

124

973

(3010421) pH of Blood

319

2657

1.21

2.70

3.4

3.9

7.42

0.25

298

2424

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

396

1.54

2.70

2.3

2.4

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.14

2.70

1.0

0.01

0.13

u/ml

1.19

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.45

2.68

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

208

1658

1.26

2.67

1.5

—

(3038026) Centromere Ab [Units/volume] in Serum

123

914

1.35

2.66

1.3

1.2

48.84

54.79

u/ml

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

101

727

1.39

2.65

1.3

—

(3033942) Copper [Moles/time] in 24 hour Urine

3.14

2.64

1.0

1.3

0.43

0.86

umol/24h

—

(3002079) Sodium [Moles/time] in 24 hour Urine

463

1.49

2.63

1.1

1.2

160.68

151.61

mmol/24h

0.32

463

(3037121) Protein [Mass/volume] in Urine

413

3530

1.18

2.62

3.0

0.24

0.32

g/l

0.91

167

1414

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

501

4348

1.16

2.62

2.1

2.0

—

(3014271) Vancomycin [Susceptibility]

472

1.49

2.61

3.0

2.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

128

960

1.34

2.61

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

297

1.62

2.61

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

358

3025

1.19

2.60

4.0

4.3

3.85

3.87

mmol/l

0.32

358

2996

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

173

1360

1.28

2.51

1.2

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

243

1987

1.23

2.50

2.5

2.7

32.68

33.97

umol/l

0.34

216

1800

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

115

855

1.35

2.50

1.1

—

(3045142) Bone marrow Pathology biopsy report

144

1108

1.30

2.47

1.4

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

107

789

1.36

2.46

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

105

772

1.36

2.45

1.4

1.5

22.58

22.63

u/ml

0.00

154

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

350

1.55

2.44

2.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

457

3964

1.16

2.43

2.0

1.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

621

1.40

2.43

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

453

3928

1.16

2.42

4.2

3.8

25.04

24.88

mmol/l

0.67

426

3614

(3034426) Prothrombin time (PT)

351

1.54

2.41

1.1

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

432

1.48

2.40

2.5

2.0

55.71

61.94

ug/l

0.33

419

(36303858) Crystals [Presence] in Urine

5.00

2.40

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

120

906

1.33

2.37

1.2

—

titre

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

118

889

1.33

2.37

1.3

1.2

126.50

69.86

u/ml

—

(40762887) Creatinine [Moles/volume] in Blood

3.64

2.36

1.0

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

291

2439

1.20

2.35

3.5

3.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

164

1294

1.27

2.34

6.6

11.61

11.78

mg/l

0.19

154

1192

(3041806) Other cells [#/volume] in Blood by Manual count

236

1.65

2.34

1.5

1.6

—

(3003181) Sodium [Moles/volume] in Urine

217

1769

1.23

2.33

1.4

64.62

63.70

mmol/l

0.12

180

1417

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

118

893

1.32

2.31

1.3

1.2

8.80

45.37

u/ml

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

199

1.71

2.30

1.7

1.3

44.86

181.08

titre

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

3.22

2.30

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

192

1.72

2.29

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

230

1.65

2.28

1.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.75

2.27

1.5

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

172

1371

1.26

2.27

1.2

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.27

2.24

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

224

1.65

2.23

1.1

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

159

1262

1.26

2.18

2.1

1.8

0.50

2.73

titre

—

(3036071) Salmonella sp Ab [Titer] in Serum

320

1.53

2.17

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

224

1848

1.22

2.17

2.9

3.1

0.77

0.83

nmol/l

1.85

173

1411

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.10

2.12

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.45

2.10

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

213

1.64

2.09

1.1

—

(3011048) Pyruvate [Moles/volume] in Blood

2.26

2.07

1.2

1.3

70.29

80.52

umol/l

0.66

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

111

850

1.31

2.04

1.7

1.8

3.48

3.93

mg/l

0.58

105

805

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

575

1.38

2.03

1.5

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

168

1356

1.24

2.02

1.2

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

451

3970

1.14

2.01

2.1

1.9

1.67

2.24

ug/l

0.78

396

3506

(3040893) Potassium [Moles/volume] in Capillary blood

3.08

2.01

2.4

2.1

4.16

4.43

mmol/l

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

450

1.42

2.00

4.8

5.1

53.75

576.85

u/ml

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

168

1358

1.24

2.00

1.2

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

737

6683

1.11

2.00

3.0

3.5

47.18

53.67

u/ml

0.31

704

6451

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

157

1260

1.25

1.99

1.5

1.6

57.18

56.81

0.04

100

768

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

104

1.92

1.99

2.1

2.9

0.89

1.31

mg/l

0.71

(3007930) Methemoglobin/Hemoglobin.total in Blood

463

4086

1.14

1.99

5.7

4.9

0.91

0.89

0.62

434

3822

(3005988) Vibrio sp identified in Specimen by Organism specific culture

168

1360

1.24

1.98

1.2

1.5

—

(3044007) Cell count panel - Peritoneal fluid

280

1.54

1.96

1.7

1.9

—

(4035726) Immunohistochemistry procedure

1051

9706

1.09

1.95

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1217

11310

1.08

1.95

3.4

4.0

8.18

24.80

ug/l

4.00

952

9045

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

648

1.34

1.95

1.3

318.00

67.93

titre

—

(3000330) Specific gravity of Urine by Test strip

584

5237

1.12

1.94

3.8

3.4

—

(3016038) Potassium [Moles/volume] in Urine

674

1.34

1.94

1.1

1.2

34.26

34.17

mmol/l

0.01

577

(40761539) Cells [Type] in Urine sediment by Light microscopy

257

1.56

1.94

1.2

—

(3024263) Appearance of Synovial fluid

531

1.38

1.90

1.2

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

618

1.35

1.87

1.1

1.2

1.09

1.06

ratio

0.21

214

(3002619) Bacteria identified in Specimen by Culture

212

1.61

1.87

1.0

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

465

4125

1.13

1.86

5.6

4.8

1.59

1.64

0.78

438

3855

(3035933) Granulocytes/100 leukocytes in Blood

292

1.51

1.86

1.2

1.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

341

1.47

1.86

1.1

1.2

20.40

24.34

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

144

1160

1.24

1.80

2.2

2.1

5.58

7.42

umol/l

1.23

105

850

(1617658) Protocol used for examination of sentinel lymph nodes

982

0.74

1.80

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

745

1.30

1.78

1.6

7.58

6.85

u/l

0.17

599

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

138

1.74

1.78

1.2

1.4

33.60

54.77

—

(21494890) Protein electrophoresis panel - 24 hour Urine

130

1039

1.25

1.75

2.2

2.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

446

3968

1.13

1.73

1.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.92

1.72

1.1

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

415

1.40

1.70

2.2

2.3

49.33

52.14

umol/l

0.28

354

(3015183) Erythrocyte sedimentation rate

517

1.36

1.69

1.1

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.89

1.64

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.03

1.64

1.0

1.1

7.24

13.71

u/l

0.90

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.93

1.64

1.0

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

353

0.59

1.61

4.6

3.6

53.69

52.37

0.10

340

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.50

1.59

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

328

1.43

1.59

1.1

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.69

1.58

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

507

1.34

1.57

1.4

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

163

1354

1.21

1.57

4.1

5.1

333.64

369.19

umol/l

2.32

136

1158

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

363

1.41

1.56

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

107

850

1.26

1.56

1.3

1.2

6.24

5.12

u/ml

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

543

1.33

1.55

1.2

1.9

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

520

4706

1.11

1.53

3.3

25.52

25.25

mmol/l

1.03

505

4565

(3022493) Free Hemoglobin [Mass/volume] in Plasma

390

1.39

1.53

1.9

4.0

62.75

985.87

mg/l

0.79

278

(3013336) Amino acids [Identifier] in Serum or Plasma

3.33

1.52

3.0

2.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

545

1.32

1.51

1.3

1.9

—

(3028433) Virus identified in Specimen by Culture

357

1.40

1.51

1.1

—

(3012441) Differential panel - Pleural fluid

123

997

1.24

1.51

1.7

1.5

—

(3006462) Nitrate [Presence] in Urine

528

1.33

1.51

3.5

3.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.86

1.50

1.0

1.2

3.83

2.81

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

460

1.35

1.49

1.1

1.0

100.12

92.94

1.01

361

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

131

1.68

1.49

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.95

1.48

1.1

1.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.37

1.45

4.2

9.2

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.50

1.45

1.0

1.8

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

252

1.47

1.44

1.4

1.3

32.72

38.35

0.41

165

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

117

1.71

1.44

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

1.77

1.44

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

2.12

1.44

1.0

—

(3004451) EKG impression Narrative

464

1.34

1.42

1.4

1.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.31

1.42

1.1

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

464

4196

1.11

1.41

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

612

0.72

1.41

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.17

1.39

1.0

1.6

—

(3008607) Semen analysis panel

2.61

1.36

1.5

1.1

—

(3012565) Volume of 24 hour Urine

520

1.31

1.36

1.9

2.1

1897.73

1940.84

0.15

463

(3016330) Potassium [Moles/time] in 24 hour Urine

135

1.63

1.35

1.4

1.2

—

87.32

—

(3005033) Fetal Nuchal fold Thickness US

198

1701

1.17

1.34

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

151

1269

1.19

1.33

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

470

1.32

1.33

2.0

1.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

224

2574

0.87

1.33

5.9

4.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.97

1.32

1.0

—

(4034850) Laboratory test

384

3457

1.11

1.29

12.2

9.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

109

891

1.23

1.28

1.4

1.3

6.08

6.42

mmol/l

0.59

817

(3047352) Trisomy 18 risk [Likelihood] in Fetus

198

1710

1.16

1.27

1.4

—

(3017509) Phencyclidine [Presence] in Urine

1.79

1.26

1.5

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

606

1.27

1.26

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

142

1682

0.84

1.25

1.8

1.7

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

170

1.53

1.25

1.0

98.39

76.25

ug/l

1.79

144

(1001926) Buprenorphine [Presence] in Urine by Screen method

270

2391

1.13

1.22

1.5

2.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

347

1.36

1.22

1.9

2.1

635.04

4513.55

e6/l

0.83

238

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.04

1.21

1.0

1.6

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

330

1.36

1.21

2.4

3.2

9.27

7.81

mg/l

0.69

264

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

495

1.29

1.21

2.3

2.1

77.15

144.96

ug/min

0.55

116

(3032057) Clostridioides difficile [Presence] in Stool

229

1.44

1.21

2.0

1.8

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

185

1597

1.16

1.21

1.3

42.35

35.36

u/l

0.33

167

1392

(3026470) Cobalt [Mass/volume] in Blood

628

1.26

1.21

2.3

1.9

3.36

3.74

ug/l

0.20

575

(3020876) Protein [Mass/time] in 24 hour Urine

134

1126

1.19

1.21

2.1

2.4

0.59

1.30

g/24h

5.88

535

(3005082) Progesterone [Moles/volume] in Serum or Plasma

461

1.30

1.19

1.3

1.4

26.80

30.51

nmol/l

0.56

405

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

156

1.54

1.19

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

170

0.53

1.17

4.6

6.1

—

(3045424) Erythrocytes [Presence] in Urine

208

1819

1.15

1.6

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

136

1152

1.18

1.14

1.6

1.5

6172.16

2906.68

e6/l

0.68

829

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

309

1.36

1.13

1.7

1.9

2717.33

16165.27

e6/l

1.28

168

(3028308) Erythrocytes [#/volume] in Pleural fluid

124

1043

1.19

1.12

1.6

1.5

113245.63

59067.03

e6/l

0.43

607

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

103

1.65

1.12

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

431

1.30

1.12

2.0

2.1

—

(3006270) Folate [Moles/volume] in Blood

108

898

1.20

1.11

1.2

396.81

361.57

nmol/l

1.16

769

(3025577) Chromium [Mass/volume] in Blood

609

1.25

1.11

2.5

2.0

2.03

2.55

ug/l

0.77

513

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

104

1248

0.83

1.10

3.5

3.8

37.76

49.15

u/ml

0.47

1230

(37021550) Renin [Units/volume] in Plasma --upright

226

1.42

1.09

1.2

1.3

68.05

74.91

mu/l

0.07

168

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

433

1.29

1.09

1.3

2.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.82

1.08

1.1

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.12

1.05

1.1

144.59

304.31

nmol/l

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.12

1.05

1.1

1.0

—

(3045788) Cell count panel - Pleural fluid

106

887

1.20

1.04

1.6

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

428

1.29

1.03

1.3

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

428

1.29

1.03

1.3

2.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.89

1.01

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

206

1822

1.13

1.00

1.4

32.91

31.17

u/l

0.26

162

1491

(3011544) Albumin [Mass/volume] in Pleural fluid

1.65

1.00

1.1

1.2

18.17

17.38

g/l

0.17

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

149

1289

1.16

0.99

2.0

2.1

32.56

32.67

0.13

149

1275

(3024932) HLA-DR beta [Type]

291

1.34

0.99

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

317

1.33

0.99

1.9

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.80

0.96

1.2

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

451

1.27

0.96

1.1

189.06

171.97

iu/ml

0.15

444

(3022689) Creatine [Moles/volume] in Urine

302

1.33

0.95

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

311

1.32

0.94

2.1

2.6

72.06

130.57

au/ml

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

390

1.28

0.94

1.1

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

199

1765

1.13

0.94

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

346

1.30

0.94

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.89

0.94

1.0

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

551

1.24

0.94

11.3

12.2

0.67

0.63

mmol/l

0.79

505

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

294

1.33

0.93

1.7

9.43

8.74

ug/l

0.48

294

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.22

0.93

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

158

1.46

0.93

2.0

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

243

1.36

0.92

1.2

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

142

1.48

0.92

1.3

1.6

157.26

111.68

ug/l

0.71

121

(4212803) Bone marrow aspirate examination

1.60

0.90

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

216

1933

1.12

0.89

1.9

1.8

0.81

0.82

nmol/l

0.04

183

1612

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

102

0.49

0.89

1.0

1.1

—

(3024471) HLA-A [Type]

297

1.31

0.88

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

153

1341

1.14

0.88

1.2

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

245

1.35

0.88

1.4

1.5

14.49

13.41

g/l

0.29

196

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.91

0.88

1.4

1.3

719.38

376.87

nmol/l

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

583

1.22

0.88

1.3

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.61

0.87

3.3

2.2

—

(3030313) Adrenal Ab [Titer] in Serum

1.58

0.87

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

170

1503

1.13

0.87

1.2

1.1

137.57

7008.35

iu/ml

0.57

358

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.72

0.86

1.5

1.7

—

(3003694) ABO and Rh group [Type] in Blood

2921

28481

1.03

0.85

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

659

1.20

0.84

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

230

1.35

0.84

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

1.74

0.82

2.5

1.9

16.71

16.58

mmol/l

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.69

0.82

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.64

0.81

1.4

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

312

1.28

0.79

1.2

36.38

38.87

g/l

0.48

166

(3009871) Measles virus Ab [Titer] in Serum

366

1.26

0.78

1.8

1.7

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.77

0.0

1.0

—

417.71

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.76

0.0

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

132

1.44

0.75

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

558

1.20

0.75

1.6

1.8

1.89

2.66

u/field

0.64

393

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.52

0.75

1.1

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.08

0.74

2.0

2.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

245

1.31

0.73

2.5

3.1

108.60

137.81

ng/l

0.35

102

(3020393) Adenovirus Ag [Presence] in Stool

108

1.48

0.73

1.8

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

134

0.60

0.73

18.9

7.1

—

(3036180) Methadone [Presence] in Urine

361

1.25

0.72

1.8

3.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.80

0.72

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

125

1.44

0.72

1.1

1.3

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.58

0.71

3.3

1.5

182.22

162.37

ug/g

—

(3013762) Body weight Measured

1.92

0.70

1.2

—

(3042733) HLA Ab [Presence] in Serum

283

1.27

0.69

5.1

4.9

—

(3016879) Cocaine [Presence] in Urine

311

2881

1.08

0.69

1.5

2.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.53

0.68

1.3

1.2

65.83

117.80

ug/l

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

248

1.29

0.68

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

248

1.29

0.68

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

213

1.32

0.68

1.4

1.2

246.33

53.03

mg/l

0.50

155

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

136

1.40

0.66

4.2

5.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

294

1.26

0.66

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

183

2014

0.91

0.65

3.9

3.2

7.63

7.58

mmol/l

0.06

178

1972

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

394

1.22

0.65

1.4

1.5

—

1160426.50

iu/ml

—

(40768806) Pleura Pathology biopsy report

117

1035

1.13

0.65

1.6

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

103

1.46

0.64

1.1

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

155

1.36

0.62

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

976

0.87

0.62

3.6

2.9

34.25

49.61

mg/l

0.46

707

(3008037) Lactate [Moles/volume] in Venous blood

195

2132

0.91

0.61

3.8

3.1

1.41

1.59

mmol/l

3.32

189

2082

(40758358) Immune stain study

1.57

0.60

1.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

165

1.33

0.60

1.8

2.4

1.21

1.20

mmol/l

0.33

159

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.54

0.59

1.8

4.4

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.59

0.0

1.0

—

12181.25

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

131

1.37

0.59

12.1

12.4

4.73

5.19

mmol/l

0.64

131

(21494434) Karyotype in Bone marrow

847

1.13

0.57

1.1

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

197

1809

1.09

0.57

1.5

1.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

539

1.17

0.57

1.9

1.5

1.26

1.24

nmol/l

0.04

421

(3002331) Protein [Mass/volume] in Peritoneal fluid

211

1.28

0.56

1.1

1.4

28.11

26.76

g/l

0.15

168

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

229

1.27

0.56

4.7

7.7

—

(3020491) Glucose [Moles/volume] in Blood

764

1.14

0.56

1.8

1.9

6.95

6.65

mmol/l

0.46

538

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.43

0.56

2.0

2.2

—

(4146454) Self-monitoring of blood glucose

1104

0.89

0.56

2.7

2.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

347

1.21

0.56

1.2

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

144

1305

1.10

0.55

1.6

1.5

33.36

32.76

g/l

0.23

133

1174

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.54

0.55

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

505

0.83

0.55

2.0

2.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

275

1.24

0.55

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

275

1.24

0.55

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

275

1.24

0.55

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

275

1.24

0.55

1.1

—

(3000285) Sodium [Moles/volume] in Blood

133

1.35

0.54

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.50

0.54

1.1

—

(40757373) Influenza virus identified in Isolate

195

1.28

0.54

1.6

1.5

—

(3048879) Bone marrow aspiration report

306

0.78

0.54

1.2

1.9

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

674

1.14

0.53

1.4

1.5

79.43

80.44

umol/l

0.08

674

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

423

1.18

0.53

2.1

130.35

134.82

umol/l

0.03

228

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

143

1.33

0.52

3.6

5.2

49.82

41.90

ug/min

0.15

110

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1273

13104

0.97

0.52

4.7

4.5

33.95

32.68

3.75

911

9013

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.62

0.52

2.0

1.1

10.98

9.05

mg/l

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

169

0.71

0.51

2.1

2.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

210

2265

0.93

0.51

3.9

3.5

21.13

26.81

mg/l

1.89

116

1399

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

273

2916

0.93

0.51

1.4

199.89

143.44

pmol/l

0.57

263

2837

(3019977) pH of Arterial blood

573

1.15

0.51

2.7

2.8

7.44

7.42

0.80

204

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

100

0.60

0.51

1.5

2.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

126

1.35

0.51

1.4

1.3

119.30

298.97

u/l

—

(3051593) INR in Capillary blood by Coagulation assay

434

1.18

0.51

5.4

12.2

—

(1761868) Lipid panel - Serum or Plasma

3643

36978

0.98

0.51

2.8

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

223

2073

1.08

0.50

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

866

1.12

0.50

1.1

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

222

2064

1.08

0.50

1.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.46

0.50

1.0

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

134

1471

0.91

0.50

1.3

7.05

7.34

mmol/l

0.67

122

1307

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

223

2075

1.08

0.49

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

222

2067

1.08

0.49

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

161

1750

0.92

0.49

3.0

3.4

1.47

1.54

0.08

146

1561

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

595

1.14

0.48

1.1

16.53

24.98

u/l

1.45

535

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

326

1.20

0.48

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

795

1.12

0.47

1.3

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

263

1.22

0.47

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

146

1.30

0.46

1.2

0.47

1.47

mmol/l

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

120

1.33

0.46

1.6

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

228

1.23

0.45

1.3

1.2

—

(40758292) HTLV I+II Ab panel - Serum

156

1.28

0.45

1.3

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.37

0.44

4.1

3.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.37

0.43

2.8

2.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

202

1.24

0.43

5.0

7.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

127

0.71

0.43

1.0

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

331

1.18

0.42

2.4

3.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1049

0.90

0.42

2.5

2.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

194

1.24

0.41

1.5

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

249

1.21

0.41

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

444

1.15

0.41

24.5

25.9

106.82

113.58

ug/l

0.36

367

(4281824) Cell count and differential, peritoneal fluid

126

1369

0.92

0.40

1.1

—

(3022670) pH of Venous cord blood

0.00

0.40

0.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.40

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.40

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.40

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.40

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.40

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.40

0.0

2.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.43

0.39

1.0

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

187

1.23

0.38

1.7

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

598

1.12

0.38

1.1

73.69

82.95

u/l

0.76

537

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

270

1.19

0.38

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

111

1208

0.92

0.38

2.6

2.2

4.03

4.05

mmol/l

0.14

111

1196

(3000764) Benzodiazepines [Presence] in Urine

329

3136

1.05

0.38

1.5

2.1

—

(3035285) Chloride [Moles/volume] in Venous blood

111

1207

0.92

0.37

2.6

2.2

105.14

105.55

mmol/l

0.44

111

1195

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

179

1.23

0.37

1.3

1.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.30

0.37

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.29

0.36

1.0

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

189

1.22

0.36

1.8

2.5

1.19

mmol/l

0.11

180

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

251

2381

1.06

0.35

2.2

2.3

60.16

92.48

ug/min

1.47

139

1396

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.33

0.35

1.0

—

7.00

—

(3004775) Volume in Urine collected for unspecified duration

785

0.90

0.35

2.2

2.3

647.75

638.75

0.07

540

(3028300) Cannabinoids [Presence] in Urine

331

3166

1.05

0.34

1.5

2.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

209

1.20

0.33

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.30

0.33

1.3

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

663

1.10

0.33

1.5

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

110

1184

0.93

0.31

2.7

2.3

—

(3027008) Opiates [Presence] in Urine

329

3157

1.04

0.31

1.5

1.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

108

1002

1.08

0.31

1.4

1.3

197609.48

118730.34

e6/l

0.39

685

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

456

1.12

0.31

1.7

1.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.30

0.30

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

337

3239

1.04

0.30

1.4

1.3

220.32

225.43

miu/ml

0.10

165

1501

(3026726) Creatinine [Moles/volume] in Specimen

1.31

0.30

3.4

2.4

340.82

443.63

umol/l

0.18

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

101

938

1.08

0.29

1.4

1.5

32.81

31.56

0.13

546

(3034891) Synovial lining cells/100 cells in Synovial fluid

487

1.11

0.29

1.4

1.5

5.85

3.70

0.29

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

248

0.85

0.28

1.8

1.9

1.88

3.27

ug/l

0.50

135

(3044927) Protein electrophoresis panel - Urine

111

1038

1.07

0.27

1.1

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

177

1.19

0.27

1.9

2.0

16.84

17.07

umol/l

0.03

177

(3014891) Appearance of Pleural fluid

122

1.23

0.27

1.3

1.2

—

(40768795) Lymph node Pathology biopsy report

118

1109

1.06

0.26

1.3

1.2

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

0.69

0.26

1.4

1.3

1962.80

1418.15

u/l

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

132

1.21

0.25

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

488

0.90

0.25

1.9

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

205

2144

0.96

0.25

3.4

3.7

40.83

35.57

u/ml

0.27

198

2077

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

477

0.90

0.25

1.3

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

704

1.08

0.25

1.3

1.4

1.18

1.24

promille

0.14

543

(3040151) Glucose [Moles/volume] in Capillary blood

124

1170

1.06

0.24

5.2

12.3

8.09

7.46

mmol/l

0.24

101

975

(3043410) Blood group antigens tested for on Red Blood Cells

283

1.13

0.24

1.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

133

1.20

0.24

1.0

—

(40768446) Kidney Pathology biopsy report

360

1.11

0.23

1.4

1.6

—

(3000012) Reticulocyte production index

150

1427

1.05

0.23

2.0

2.1

—

(46236302) HLA-C [Type] by High resolution typing

1.32

0.23

1.0

—

(40760410) HLA-B [Type] by High resolution

1.32

0.23

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

1.32

0.23

1.0

1.2

—

(40763590) HLA-DQ beta [Type]

1.32

0.23

1.0

—

(40760409) HLA-A [Type] by High resolution

1.32

0.23

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

991

0.94

0.23

1.2

—

(3013862) HLA-DP [Type]

1.25

0.22

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

815

1.07

0.22

2.1

2.0

2.86

2.02

u/field

0.45

335

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

122

1156

1.06

0.22

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

535

0.92

0.22

1.4

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

362

1.11

0.22

3.4

2.8

27.02

28.75

umol/l

0.66

277

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.5

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.5

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.21

0.0

1.0

—

20.80

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

2.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.2

—

71.41

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

884

0.94

0.21

1.6

1.3

1.62

1.48

nmol/l

0.49

783

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(40762365) Oxygen content in Arterial blood by calculation

164

1.16

0.20

2.2

2.9

15.33

14.99

ml/dl

0.23

153

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

752

1.06

0.19

1.8

1.7

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.22

0.19

1.5

2.2

1.35

1.32

umol/l

0.11

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

685

1.07

0.19

1.4

1.3

12.38

12.60

u/l

0.06

629

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

175

1.14

0.18

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

175

1.14

0.18

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

531

1.07

0.18

2.4

2.3

192.05

203.92

u/l

1.22

526

(40768441) Liver Pathology biopsy report

784

1.06

0.18

1.5

1.3

—

(40762814) Titanium [Mass/volume] in Blood

166

1.14

0.18

2.9

2.2

3.36

3.87

ug/l

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

119

1.18

0.17

1.1

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

119

1.18

0.17

1.0

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

119

1.18

0.17

2.2

3.5

39.86

39.26

umol/l

0.04

102

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

507

0.93

0.17

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

507

0.93

0.17

1.2

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

310

0.90

0.17

3.4

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

310

0.90

0.17

3.4

2.8

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.13

0.17

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

119

1138

1.05

0.17

2.9

4.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

354

3455

1.03

0.17

1.7

1.9

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

224

1.12

0.17

1.4

1.5

69.63

120.36

ng/l

4.55

224

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

101

1.19

0.16

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

378

3863

0.98

0.15

1.4

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

172

0.87

0.15

1.3

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

224

0.89

0.15

2.3

2.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

245

1.10

0.15

1.1

—

(3027944) Amphetamines [Presence] in Urine

319

3117

1.02

0.15

1.5

2.0

—

(3020650) Glucose [Presence] in Urine

255

1.10

0.15

2.0

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

228

1.10

0.13

1.1

1.2

—

403.08

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

195

1899

1.03

0.12

1.4

1.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

221

0.90

0.12

2.9

2.3

6.94

7.74

mmol/l

0.36

137

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

210

1.10

0.12

1.1

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

611

6030

1.01

0.12

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

162

1.11

0.11

1.4

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

201

1.09

0.11

1.2

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

224

2193

1.02

0.10

2.6

3.4

246.54

560.00

u/ml

1.10

200

2004

(40768793) Breast Pathology biopsy report

286

2809

1.02

0.10

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

633

1.04

0.10

1.3

1.60

1.58

g/l

0.33

633

(3009015) Lactate [Moles/volume] in Synovial fluid

125

0.88

0.10

1.2

4.24

6.11

mmol/l

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

135

0.89

0.09

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

135

1.11

0.09

1.8

2.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

227

0.92

0.09

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.13

0.09

1.9

2.1

—

(3019174) dRVVT (LA screen)

1.13

0.09

1.1

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

105

1080

0.97

0.09

3.1

3.4

57.56

56.42

0.25

915

(3017569) Oxygen content in Arterial blood

498

1.04

0.08

2.0

2.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

243

1.07

0.08

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.05

0.08

1.2

1.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

148

1447

1.02

0.08

3.8

2.7

13.25

13.22

0.10

148

1430

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

107

1.12

0.08

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

175

1.09

0.08

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.83

0.08

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.83

0.07

1.5

4.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

143

0.91

0.07

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

226

2226

1.02

0.07

1.4

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

304

1.05

0.07

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

438

0.96

0.07

2.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

255

0.94

0.07

1.4

1.3

526.14

448.36

ug/l

0.05

143

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

118

1.10

0.07

2.7

2.9

2.06

1.31

mmol/l

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.05

0.07

3.6

5.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.12

0.06

1.6

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

681

1.03

0.06

1.2

1.4

—

(40765096) Chromosome analysis panel by Banding

293

0.96

0.05

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

137

1391

0.98

0.05

1.4

1.5

—

(3035880) pH of Pleural fluid

526

1.03

0.04

1.4

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

895

8987

1.00

0.04

1.7

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

109

0.92

0.04

10.6

5.8

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

109

0.92

0.04

5.3

2.9

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

478

1.03

0.03

2.8

3.5

—

(40768800) Prostate Pathology biopsy report

162

1604

1.01

0.03

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

669

1.02

0.02

1.2

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

257

2586

0.99

0.02

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

123

1.06

0.01

2.8

2.6

0.54

0.63

u/field

0.15

123

(3044009) aPTT.lupus sensitive (LA screen)

1.06

0.01

1.1

1.2

—

(3042517) Benzodiazepines panel - Urine

1.03

0.00

1.7

2.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

107

1.03

0.00

1.3

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

107

1.03

0.00

1.2

3.4

5.92

7.37

mmol/l

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

127

1.02

0.00

1.2

—

(3016750) Collection duration of Urine

563

0.99

0.00

2.0

2.2

502.11

497.04

min

0.16

426

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

104

1043

1.00

0.00

1.2

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

155

1.03

0.00

5.4

7.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

185

0.97

0.00

1.4

1.2

1.50

1.71

mmol/l

—

110

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

102

0.98

0.00

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

128

1.02

0.00

1.1

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

142

0.99

0.00

3.0

2.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

122

1218

1.00

0.00

1.7

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

109

1.01

0.00

1.9

2.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

141

0.99

0.00

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.02

0.00

2.8

2.3

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

1.8

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.96

0.00

1.0

1.4

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.96

0.00

1.3

1.0

—

(3032641) Amino acids panel - Urine

0.00

0.0

1.6

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.4

—

23.08

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

-0.00

0.0

1.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.91

-0.00

1.0

1.1

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

-0.00

0.0

1.5

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

7.2

—

12.50

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.97

-0.00

1.3

1.5

309.33

329.31

umol/24h

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.94

-0.00

1.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.94

-0.00

1.6

1.3

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

220

1.00

-0.00

2.3

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.2

—

35.17

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

460

1.00

-0.00

1.1

1478.11

1546.29

miu/ml

0.15

460

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

2.1

—

9.56

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_VOICE_DISTU – Voice disturbances

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Voice disturbances

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Voice disturbances (R18_VOICE_DISTU)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints